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Chapter 1
Introduction
Cancer is a major public health problem. Currently, one in four deaths in the
United States is due to cancer [25]. A total of 1,372,910 new cancer cases and
570,280 deaths are expected in the United States in 2005. When deaths are
aggregated by age, cancer has surpassed heart disease as the leading cause of
death for persons younger than 85 since 1999 [25]. The three most common
cancer sites for men are lung and bronchus, colon and rectum, and prostate.
The most common sites for women are breast and colorectal [25]. According
to the “Centraal Bureau voor de Statistiek” (CBS, www.cbs.nl) cancer will be
the leading cause of death in the Netherlands by the year 2010. These numbers
justify a strong interest for this subject from researchers.
There are a few widely accepted causes of cancer, for instance tobacco [12].
Although many forms of cancer are sporadic, there are some cancers with a
hereditary component, such as breast cancer, which has been related to genes
named BRCA1 and BRCA2 (BRCA stands for breast cancer) [19].
Cancer results from molecular events that change the properties of human
cells. In cancer cells the normal control systems that prevent cell overgrowth
and the invasion of other tissues are disabled.
The abnormalities in cancer cells usually result from aberrations in genes
that regulate cell division. Over time more genes become aberrated. This is
often because the genes that make the proteins that normally repair DNA dam-
age are themselves not functioning normally, because they are also aberrated.
Consequently, aberrations begin to increase in the cell, causing further abnor-
malities in that cell. Some of these aberrated cells die, but other alterations
may give the abnormal cell a selective advantage that allows it to multiply
much more rapidly than normal cells.
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Cancer research Machine learning
Diagnosis Classification
Tumor class discovery Clustering
Biomarker identification Feature selection
Table 1.1: Schema of machine learning in cancer research.
1.1 Motivation
Recent technological developments in molecular biology provide the opportu-
nity to perform large scale measurements at the various “information levels” in
the human cell: chromosomal DNA copy numbers, gene expression and protein
expression. The analysis, presentation and interpretation of the vast amount
of numerical data are a major challenge.
A particular type of experiment, called array CGH, provides data that
should allow us to estimate chromosomal copynumber changes. In this thesis
the problem of the experimental noise generated by this type of experiment
is addressed. Furthermore a method is presented that allows us to perform a
cross platform analysis of this type of data. This is interesting, since comparing
many different studies may provide interesting new insights.
A second type of experiment is micro-array gene expression experiments
that provide the opportunity to compare expression profiles of healthy persons
and those who suffer from cancer. It is interesting to test the predictive power
of these profiles, as a good predictor could be used for diagnosis. A novel
clustering method based on the classification method called support vector
machine (SVM) is presented to do so.
Mass spectra proteomics experiments give insight in the amount of small
peptides and proteins present in cancer and healthy samples. Since proteins
are responsible for much of the behavior of human cells, such experiments may
provide sufficient information to perform a successful diagnosis. Furthermore
an understanding of which proteins are important in certain types of cancer is of
fundamental relevance, since it may lead to development of novel medicines. For
this task a novel feature selection method based on evolutionary computation
and SVMs is presented.
1.2 Machine learning in cancer research
Some cancer research questions can be associated with machine learning tasks.
Table 1.1 shows some instances of this observation that are addressed in this
thesis. In the following sections of this introduction we discuss the associations
in table 1.1 in more detail and briefly discuss the laboratory and machine
learning techniques that are considered in this thesis.
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Classification for diagnosis
A classifier is a function from the set of possible examples to the set of possible
classes. Typically the function has some parameters which need to be esti-
mated. This is done by a learning algorithm, by using a number of examples
with desired class given.
Diagnosis can be described as the process of identifying a disease by the
symptoms. We can use a classifier for diagnosis of a single disease if we take the
set of possible classes to be healthy or disease. The examples have values for a
number of variables that are thought to be sufficient for diagnosis. What makes
a good classifier depends on the application. In traditional machine learning
we are looking for probably approximately correct (PAC) classifiers. That is,
the probability that we make more than a certain number of misclassifications
should be small.
In diagnostics a classification system may be used to make a “first selec-
tion”. The patients who are almost certainly healthy should not be investigated
further. To be more specific, if a patient is tested to indicate the presence of
cancer, the result is “positive” if cancer is present, and “negative” if it is not.
Suppose we have a set of patients for which we know whether they have cancer
or not. For the applied test we can determine the number of patients correctly
diagnosed to have cancer (true positive, tp), falsely diagnosed to have cancer
(false positive, fp), correctly diagnosed not to have cancer (true negative, tn)
and finally falsely diagnosed not to have cancer (false negative, fn). For a “first
selection” a small number of false negatives is more important than a small
number of false positives. In other words sensitivity (tp / (tp + fn)) is more
important than specificity (tn / (tn + fp)) in this case.
Clustering for tumor class discovery
Clustering is the process of discovering groups of related examples. In contrast
to classification, this process is not guided by knowledge about the proper
grouping of some examples. The result of clustering can be described as a set
partition of the examples. So the result is a collection of disjoint subsets of
the data, whose union is the complete data set again. In tumor class discovery
the found subsets are supposed to correspond to discovered tumor subtypes.
A different approach is taken in hierarchical clustering. This process leads to
a binary tree structure with the examples as leaf nodes. Examples that are
connected by internal nodes that are relatively far from the root, can be seen
as clusters. A clustering is considered successful if patterns within each group
are more similar to each other than to patterns in other groups.
Feature selection for biomarker detection
Feature selection is a procedure which identifies relevant features of the set of
patterns. In a supervised setting “relevant” is with respect to the class. A
biomarker is an indicator of a disease. As in classification for diagnosis, the
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Data type Laboratory technique
Chromosomal aberrations Array CGH
Gene expression Expression array
Protein expression Seldi-Tof
Table 1.2: Laboratory techniques.
Data type
\ Research
topic
Diagnosis Class discovery Biomarker
Chromosomal
aberrations
[27], Chapter 5 and 6
Gene expres-
sion
[27], Chapter 6
Protein
expression
[28], Chapter 7 [28], [26], Chapter 7
Table 1.3: Thesis outline.
class can be chosen to indicate the disease. The relevant features found form a
potential biomarker.
1.3 Thesis outline and summary
Since we have analyzed data involving DNA, RNA and proteins it makes sense
to use the central dogma of molecular biology as a guide for structuring this
thesis. The dogma can be summarized as: DNA is transcribed into RNA which
in turn is translated into proteins. Table 1.3 shows which type of data is used for
the several cancer research topics in this thesis. The thesis begins with a brief
introduction to the molecular biology (chapter 2) and computational methods
(chapter 3). The next sections contain the main contributions, depending on
the reader’s background it may be useful to first read chapter 2 or 3. Finally,
a conclusion is presented (chapter 8).
We summarize below the content of the main chapters of the thesis, using
the considered data (see Table 1.2) for structuring the presentation.
1.3.1 Chromosomal aberrations
Introduction Chromosomal aberrations that are present in many tumors may
indicate the presence of an oncogene or a tumor suppressor gene.
Data Array CGH experiments provide data that should allow us to estimate
copynumber changes.
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Problem There are many sources of noise in the data. The labeling and
hybridization may be uneven. So called cross hybridization causes gains
and losses to become less clear. Cross hybridization is the phenomenon
that pieces of chromosomal DNA hybridize to random spots. On average
this adds an equal amount of material to both channels. If this amount
becomes large, the ratio of both channels goes to one. Furthermore, the
measured tumor sample may be inhomogeneous. It may contain some
normal cells and cells from intermediate stages of the tumor pathogenesis.
Approach To overcome these problems we created a “smoothing” method.
It is based on relatively simple assumptions. More sophisticated models
could be used if we would have more insight in tumor pathogenesis and
the processes involved in the experiments. The approach uses a maximum
likelihood criterion and an evolutionary algorithm.
Results The results of the algorithm are comparable to those obtained by
an expert. The software to perform the “Smoothing” is available on
the website www.few.vu.nl/~vumarray. The algorithm has also been
incorporated in commercial software.
Chapter 4
Reference [30]
1.3.2 Meta-analysis of array CGH
Introduction Several dual channel array CGH platforms are available today.
Comparing experiments from these different platforms may provide valu-
able insights, however this is not a trivial task.
Data 373 Array CGH primary cancer experiments and 61 cell line experiments
from several dual channel platforms: cDNA, BAC and Oligo.
Problem Array CGH data from different platforms cannot be compared di-
rectly, since each platform contains different numbers of clones at variable
spacing and resolution, and the noise distribution varies across platforms,
as well as the amplitude for a given copy number change. Finally, the
way each institute collects and processes the spotted elements of the can-
cer samples may introduce specific noise in the data and influence the
dynamic range.
Approach We developed a five-step preprocessing methodology to overcome
these problems. Subsequently, a cell line data set was used to optimize
the settings for the preprocessing and hierarchical clustering. Next, we
applied the procedure to the primary cancer data.
Results We show that currently available array CGH data can be used for
a meta hierarchical clustering. Different platforms are used by different
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institutes, which results in different types of noise. This is done by, among
others, using the smoothing algorithm.
Chapter 5
1.3.3 Clustering gene expression data
Introduction The gene expression profile of a tumor is thought to be one
of the most important characteristics of a tumor, since gene expression
determines to a large extent the behavior of a cell.
Data We consider five data sets from micro-array gene expression experiments.
Problem A SVM is a powerful technique for classification and regression. It
is interesting to apply characteristics of this technique to clustering of
gene expression data.
Approach We introduce a heuristic method for non-parametric clustering that
uses support vector classifiers for finding support vectors describing por-
tions of clusters and uses a model selection criterion for joining these
portions. Clustering is viewed as a two-class classification problem and a
soft-margin support vector classifier is used for separating clusters from
other points suitably sampled in the data space.
Results The results indicate that the method is a fairly robust clustering
method, capable of identifying the “true” structure in the considered
data sets.
Chapter 6
Reference [27]
1.3.4 Proteomics
Introduction Proteins determine the behavior of cells. This suggests that
proteomics analysis may provide sufficient information to perform a suc-
cessful diagnosis. Furthermore an understanding of which proteins are
important in certain types of cancer is of fundamental relevance.
Data Two proteomic pattern data sets (SELDI-TOF) containing measure-
ments from ovarian and prostate cancer samples.
Problem The problem is to construct a classifier that successfully separates
the cancer class of samples from the healthy ones. Moreover, we want
to identify those features from the data that are most important for
classification.
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Approach A linear and a quadratic SVM are applied to the data for dis-
tinguishing between cancer and benign status. The prostate dataset is
further analyzed by means of an evolutionary algorithm for feature selec-
tion that searches for small subsets of features in order to optimize the
SVM performance.
Results On the ovarian data set, SVM with all the features exhibits excellent
diagnostic performance, while on the prostate dataset it obtains relatively
low sensitivity. Results show that the performance of the algorithm on the
prostate dataset depends on the data splitting and “run” of the algorithm.
Moreover, feature subsets generated vary per run, with a small core of
features occurring more often.
Chapter 7
Reference [28]
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Chapter 2
Biological background
This chapter provides a minimal background in biology to better understand
the remainder of the thesis. A more elaborate introduction can for instance be
found in [32].
2.1 Human cells
All organisms consist of cells. Each cell is a system with many different building
blocks enclosed in a membrane. Cells can be of different types. For instance
there are skin cells, muscle cells and brain cells (neurons).
A human cell has a nucleus, which is separated from the rest of the cell by
a membrane. The nucleus contains chromosomes, which are the carrier of the
genetic material. Within human cells there are structures, called organelles,
e.g., centrioles, lysosomes, golgi complexes, mitochondria among others, which
perform particular biological processes. The area of the cell outside the nucleus
and the organelles is called the cytoplasm. Membranes are a barrier to the
environment, and regulate the flow of food, energy and information in and out
of the cell.
Human life begins as a single cell, as a result of fusion of a male and a
female sex cell (gametes). The single cell has to grow, divide and differentiate
into different cell types to produce tissues and organs. The growth of a cell
and its division is called the “cell cycle”.
There are three important types of biological macromolecules involved in
cells:
1. DNA
2. RNA
3. Proteins
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DNA (DeoxyriboNucleic Acid) is the main information carrier molecule in a
cell. DNA may be single or double stranded. A single stranded DNA molecule,
also called a polynucleotide, is a chain of small molecules, called nucleotides.
There are four different nucleotides grouped into two types, purines: adenosine
and guanine and pyrimidines: cytosine and thymine. They are usually referred
to as bases, since the bases are the only distinguishing element between different
nucleotides. They are denoted by their initial letters, A, C, G and T. Any
number of nucleotides can be linked together to form a polynucleotide. Specific
pairs of nucleotides can form bonds between them. A binds to T, C binds to G.
The A-T and G-C pairs are called base-pairs. Two polynucleotides are called
complementary, if one can be obtained from the other by exchanging A with
T and C with G. Two complementary polynucleotides can stick together. Two
complementary polynucleotide chains form a stable structure, which resembles
a helix.
RNA is constructed from nucleotides, like DNA. But instead of the pyrim-
idine thymine (T), it has uracil (U), which is not present in DNA. Messenger
RNA is single stranded.
Proteins are the main building blocks and functional molecules of the cell. A
protein consists of amino acids joined by peptide bonds. The amino acid chains
are folded into 3-dimensional structures. Proteins have varying functions in the
cell, some are enzymes, and some have structural or mechanical roles in the
cytoskeleton, while others may determine immune response.
2.1.1 Chromosomes
Chromosomes are strands of DNA. Both ends of the chromosome are called
telomeres. A chromosome has two “arms” connected by a centromere. The
shortest is called “p”, the other “q”. Chromosomes are commonly shown in
the mitosis state metaphase, when they are duplicated and wound up so that
they are visible under an optical microscope. These duplicated chromosomes
are called dyads. The duplicates are held together at their centromeres.
All animals have a characteristic number of chromosomes in their cells called
the diploid (or 2n) number. These occur as homologous pairs, one member of
each pair is acquired from the gamete of one of the two parents of the individual.
The complete set of chromosomes in the cells of an organism is its karyotype.
The karyotype of humans contains 22 pairs of so called autosomes. In addi-
tion a female has a pair of X chromosomes. A male has one X chromosome and
one Y chromosome. The X and Y chromosomes are called the sex chromosomes.
The majority of human DNA is identical in all humans.
A gene is a region of chromosomal DNA that controls a hereditary char-
acteristic. It usually corresponds to a sequence used in the production of a
specific protein or RNA. A gene carries biological information in a form that
is copied from each cell to all its progeny. The locus is a place on a specific
chromosome where a gene is found.
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(a) Prophase (b) Metaphase
(c) Anaphase (d) Telophase
Figure 2.1: Mitosis.
2.1.2 The cell cycle
The cell cycle is the set of events resulting in cell growth and division. The
stages are called G1, S, G2 and M. The G1 stage stands for “GAP 1”. In this
phase cells increase in size, produce RNA and proteins. The S stage stands
for “Synthesis”. In this stage DNA replication occurs. The G2 stage stands
for “GAP 2”. During this phase the cell continues to grow and produce new
proteins. The M stage stands for “Mitosis”. Mitosis is nuclear division plus
cytokinesis, and produces two identical cells in four stages called prophase,
metaphase, anaphase, and telophase.
Prophase, see figure 2.1a. The cell contains two so called centrosomes. The
two centrosomes move in opposite directions towards the border of the cell.
Some fibers (microtubules) grow out of each centrosome. This set of fibers is
called the “mitotic spindle”.
Metaphase, see figure 2.1b. The membrane around the nucleus disappears.
Some protein structure (kinetochore) appears at the centromere of each chro-
matid (one of two chromosomes after duplication, but before their separation).
The microtubules attach to the kinetochores and to the arms of the chro-
mosomes. Both kinetochores are attached to different centrosomes. In the
metaphase all the chromatids reach a position midway between the centro-
somes.
Anaphase, see figure 2.1c. The two kinetochores at both chromatids sepa-
rate and each moves to its centrosome dragging its attached chromatid (chro-
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Figure 2.2: Central dogma.
mosome) behind it.
Telophase, see figure 2.1d. A nuclear membrane forms around each of both
groups of chromosomes.
Cytokinesis. A ring forms around the cell. As the ring tightens, the cell is
divided into two cells.
Obviously, this is a simple summary of the process. However, during this
cycle errors can occur, leading to chromosomal aberrations, which in turn can
lead to cancer.
2.1.3 The central dogma of molecular biology
DNA contains the complete genetic information that defines the structure and
function of a human. Proteins are formed using the genetic code of the DNA.
Three different processes are responsible for its conversion from one form to
another.
During transcription one strand of DNA molecule is copied into a comple-
mentary pre mRNA (preliminary messenger RNA). In the process the two-
stranded DNA double helix is unwound and information is read from one
strand.
Splicing removes some pieces of the pre mRNA, called introns. The remain-
ing sections called exons are joined. An exon is the part of the gene that codes
for a protein. The result of splicing is mRNA. The mRNA moves from the
nucleus into the cytoplasm.
During translation the mRNA sequence is translated into a sequence of
amino acids as the protein is formed. The ribosome reads three nucleotides (a
codon) at a time from the mRNA and translates them into one amino acid.
Transfer or tRNA molecules each carry a specific amino acid to the ribosome
and specifically recognizes one codon on the mRNA. The amino acid carried
by the tRNA is added to the protein.
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These processes, except the splicing, are illustrated in figure 2.2.
2.2 Human cancer
Cancer is a disease in which cell division becomes uncontrolled. Cancer results
from molecular events that change the properties of cells. In cancer cells the
normal control systems that prevent cell overgrowth and the invasion of other
tissues are disabled.
The cells that divide in an uncontrolled way form a tumor. This process
can be malignant or benign, meaning life threatening and not dangerous, re-
spectively. A malignant tumor invades surrounding organs and tissues, this
process is called metastasis. Tumors from organ cells are called carcinomas.
Tumors from the internal or external surface of the body are called adenomas.
The abnormalities in cancer cells usually result from mutations in genes
that regulate cell division. Over time more genes become mutated. This is
often because the genes that make the proteins that normally repair DNA
damage are themselves not functioning normally, because they are also mu-
tated. Consequently, the number of mutations begins to increase in the cell,
causing further abnormalities in that cell. Some of these mutated cells die, but
other alterations may give the abnormal cell a selective advantage that allows
it to multiply much more rapidly than normal cells.
Malfunctioning genes can be classified into three groups. The first group,
called proto-oncogenes enhance cell division. The mutated forms of these genes
are called oncogenes. The second group, called tumor suppressors prevent cell
division. The third group is DNA repair genes, which prevent mutations that
lead to cancer.
Aberrations that increase the copy number of oncogenes accelerate growth
while those that decrease the copy number of tumor suppressors prevent the
normal inhibition of growth. In either case, uncontrolled cell growth occurs.
The conversion of a proto-oncogene to an oncogene may occur by mutation
of the proto-oncogene, by rearrangement of genes in the chromosome that moves
the proto-oncogene to a new location, or by an increase in the number of copies
of the normal proto-oncogene.
Tumor suppressor genes normally inhibit cell growth, preventing tumor
formation. Mutations in these genes result in cells that no longer show normal
inhibition of cell growth and division.
A third type of gene associated with cancer is the group involved in DNA
repair and maintenance of chromosome structure. Environmental factors, such
as UV light, and chemicals, can damage DNA. Errors in DNA replication can
also lead to mutations. Certain gene products repair damage to chromosomes,
thereby minimizing mutations in the cell. When a DNA repair gene is mutated
its product is no longer made, preventing DNA repair and allowing further
mutations in the cell.
There are several types of chromosomal aberrations that can occur in cancer
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Figure 2.3: Micro-array.
cells. A piece of chromosome can have more than the normal two copies. We
say that piece has a gain. A piece of chromosome may also have only one
copy or even no copies. This situation we call a loss or double loss. The
final type of aberration occurs when a part of a chromosome has moved to a
different location. We call this event relocation. It should be noted that not
all aberrations cause cancer.
2.3 Micro-arrays
Micro-arrays are glass slides onto which DNA (cDNA or oligonucleotides) are
attached, at known locations (probes, spots or targets). An oligonucleotide, or
oligo as it is sometimes called, is a short fragment of a single-stranded DNA.
Each spot contains material that corresponds to a known gene or location on
the genome.
The process is based on hybridization. It uses fluorescently labeled nucleic
acid molecules to identify complementary molecules. When two complementary
sequences find each other, such as the target DNA and the cDNA in the sample
solution, they will stick together or hybridize. Figure 2.3 shows a schematic
representation of the process.
There are two types of experiments that can be done. One measures relative
chromosomal DNA copy number levels, the other measures relative mRNA or
gene expression levels. Some details of the hybridization steps in both methods
are given in the next sections. After this hybridization step, the micro-array
is placed in a “reader” or “scanner” that consists of some lasers, a special
microscope, and a camera. The fluorescent tags are excited by the laser, and
the microscope and camera create a digital image of the array.
Image analysis software identifies the spots on the array. Then it calculates
intensities of sample DNA, control DNA and background. From these values
relative expression or copy number levels can be calculated.
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Figure 2.4: Seldi-Tof.
2.3.1 Array CGH
Micro-array Comparative Genomic Hybridization (array CGH) is a technique
to look for genomic gains and losses. The hybridization mixture will contain
fluorescently labeled genomic DNA obtained from both normal (reference) and
cancer tissue. If the number of copies of a particular area has increased, a large
amount of sample DNA will hybridize to those spots on the micro-array that
represent the area involved in that disease, whereas relatively small amounts
of control DNA will hybridize to those same spots. This technique does not
notice chromosomal relocations.
2.3.2 Expression arrays
The target DNA is cDNA derived from the mRNA of known genes and the
control and sample DNA hybridized to the chip is cDNA derived from the
mRNA of normal and diseased tissue, respectively. If a gene is over (under)
expressed in a certain disease state, then more (less) sample cDNA, relative to
control cDNA, will hybridize to the spot representing that gene.
2.4 Seldi Tof
Proteomics is the study of protein expression and function. Once the pro-
teins are extracted from the sample, a number of techniques are available to
separate the different proteins from each other to measure their intensities.
Surfaced-Enhanced Laser Desorption/Ionization Time-of-Flight (Seldi-Tof) is
one of them.
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Figure 2.5: A typical protein profile produced by SELDI-TOF MS. The y-
axis shows the relative abundance of ionized peptides. The x-axis shows their
mass-to-charge (m/z) ratios.
In the Seldi approach a biological sample is spotted onto a solid surface
(probe or ProteinChip). Seldi uses selective probe surfaces to capture only
a fraction of proteins in a sample. After the sample is put on the probe,
the surface is washed to remove all unbound molecules. The probe contains
compounds that absorb the energy of light at a particular wavelength. The
probe is then inserted into a device with a laser that can fire at the proper
wavelength. The energy absorbing molecules transmit some of the energy to
the peptides and proteins in the sample. This causes the sample to vaporize.
The proteins and peptides are ionized by chemical processes. The ion gas is
accelerated into the mass analyzer using electric fields. The amount of kinetic
energy for each ion depends on its charge. If two ions have the same charge,
their kinetic energy will be the same. Since the velocity given the kinetic energy
depends on the weight of the ion, larger ions will move slower. Measuring the
time of flight to the detector therefore gives the weight of the ion. Spreads in
the amount of initial kinetic energy will cause some inaccuracy. The process is
illustrated by figure 2.4.
The Seldi-Tof technology produces a graph of the relative abundance of
ionized peptides (y-axis) versus their mass-to-charge (m/z) ratios (x-axis). (Cf.
Figure 2.5) The m/z ratios are proportional to the peptide masses, but the
technique is not able to identify individual peptides, because different peptides
may have the same mass and because of limitations in the m/z resolution.
Currently the graph is represented by 15000 measuring points. There is no
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obvious relation between neighboring measurement points, apart from the fact
that they refer to peptides of similar masses and that the resolution is such that
the graph should be considered a smoothed version of the true mass density.
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Chapter 3
Machine learning
background
3.1 Optimization by evolutionary computation
A more thorough introduction to the subject of this section can be found in
[14].
Evolutionary algorithms (EAs) are search methods inspired by natural se-
lection and survival of the fittest in biology. EAs involve a search from a
population of candidate solutions. Each iteration of an EA involves a compet-
itive selection that discards poor candidate solutions in a stochastic way. The
algorithm constructs variations of the candidate solutions. Two types of varia-
tion are recombination and mutation. Recombination refers to the process that
recombines candidate solutions randomly with other solutions by exchanging
parts. Mutation refers to the process that makes a random change to a sin-
gle element of a candidate solution. Recombination and mutation are used to
generate new solutions that are biased towards regions of the space for which
good solutions have already been seen.
Evolutionary computation is traditionally divided into four types of algo-
rithms: genetic algorithms, genetic programming, evolutionary strategies and
evolutionary programming. The algorithms are all loosely based on the “sur-
vival of the fittest” principle from Darwin’s evolution theory.
These algorithms are used for optimization problems where many candidate
solutions are possible (large search space), but finding an optimal or even good
solution is difficult. If the search space is small an exhaustive search is possible.
Other search algorithms are for instance random walk or gradient descent. It
seems that evolutionary search performs better than random search and is less
vulnerable to local optima than gradient descent.
The main distinctive feature of evolutionary search techniques is their use
of a population of solutions, and when recombination is used, the fact that new
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Evolut ionary Algorithm
Generate i n i t i a l populat ion
Determine f i t n e s s o f populat ion
Repeat un t i l t e rminat ion c r i t e r i o n i s met
S e l e c t parents
Apply reproduct ion operators , producing o f f s p r i n g
Determine f i t n e s s o f populat ion
S e l e c t s u rv i v o r s next gene ra t i on
End repeat
Figure 3.1: Outline of an evolutionary algorithm.
solutions are created by two or more old ones.
An important remark for biologists is that the evolutionary computation
techniques are based on biological evolution on a high level, but they are not
intended to be a realistic model of biological evolution. Aspects of biological
evolution can be left out, or extended without biological motivation.
Figure 3.1 gives an outline of a general evolutionary algorithm. The pop-
ulation consists of individuals that represent candidate solutions to the opti-
mization problem. The initial population is filled with some individuals. Then
an iteration is started. Each iteration corresponds to a generation in the evolu-
tion. The termination criterion typically depends on the maximum individual
fitness, or on the amount of change that is observed in the population over the
generations. The fitness function indicates the quality of an individual in the
population.
The selection of the parent population is based on the fitness of the individu-
als. Two popular approaches are “roulette wheel” and “tournament selection”.
In roulette wheel, each individual gets a selection probability proportional to
its fitness. In tournament selection a set of k potential parents is chosen at
random from the population. The individual with the highest fitness among
those individuals is chosen as parent.
A distinction can be made in the reproduction operators. Mutation oper-
ators only use one individual to produce offspring. Recombination operators
typically use two parent individuals to produce two offspring individuals.
Next to this we need a representation for the solutions. The kind of re-
production operators used is closely related to the chosen representation. The
main difference between the four types of algorithms in evolutionary computa-
tion lies in these properties.
In genetic algorithms (GAs) the representation of individuals is often a
bit string. Operators that are sometimes used are crossover and mutation.
Crossover is a type of recombination. It generates two offspring from two parent
bitstrings by exchanging parts of the parent bitstrings. Mutation changes one
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bit in the bitstring. Mutation is applied after the cross-over.
In genetic programming (GP) the representation is a tree. The nodes are
functions, variables or values. Function nodes can have children which represent
the arguments of the function. Operators are typically subtree crossover and
subtree mutation. Subtree mutation takes from both parents a node (and the
trees under them) and exchanges them. Subtree mutation takes one node in
the tree and replaces it by another (random) subtree.
In evolutionary strategies (ESs) the representation is a string of real val-
ues. A possible recombination operator is intermediate recombination, which
generates one offspring from a number of parents by taking the mean of each
element of the parent vectors. Gaussian mutation adds a Gaussian generated
value to each of the elements. Selection of survivors in ES is divided into two
types, named (µ, λ) and (µ+ λ). The population is of size µ and λ individuals
are selected to be parents in both. In (µ+ λ) the λ parents are always chosen
to be among the survivors.
In evolutionary programming the representation depends on the problem.
The main difference with other evolutionary approaches is that no recombina-
tion operators are used, only mutation.
As mentioned earlier, evolutionary computation does not pretend to be a
model for biological evolution. An example of this can be found in an applica-
tion of Lamarckian evolution. The Lamarckian evolution theory describes that
traits learned by an individual during its lifetime can be inherited through
reproduction by next generations. This theory is not generally accepted by
biologists since no biological mechanism seems to be present to achieve this.
In evolutionary computation however this can be achieved by applying some
specialized search strategies, like local search, to the individuals of the popu-
lation.
The survivors for the next generation do not need to be selected in a stochas-
tic way. For some problems it may be beneficial always to choose the fittest
individual among the survivors. This prevents the accidental removal of a very
good candidate solution. This approach is called elitism.
Finally, it should be noted that candidate solutions are often referred to
as chromosomes or individuals. In this thesis the word chromosome for candi-
date solutions may lead to confusion and is therefore used sparsely with this
meaning.
3.2 Classification by support vector machines
This section provides a basic introduction to SVMs. More comprehensive in-
troductions can be found in [10, 20].
SVMs can be used for classification. They view the numerical examples as
points in a space. The examples belong to two classes. The SVM searches a
linear (hyper)plane that separates the points in the space.
If the points of both classes are linearly separable, many potential planes are
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possible. The SVM chooses the plane that maximizes the minimum distance
of all points from the two classes to the plane.
Extensions to this basic concept include the ability to deal with non-linearly
separable data in two ways. The first way is to allow some examples to be on
the wrong side of the separating plain. The SVM does include a penalty term
that discourages the selection of such planes. The second way is to map the
original data into another space by a so called kernel function. This new space
is commonly called feature space. The SVM then searches a linear plane in
feature space. By proper selection of the kernel function this allows for many
types of non-linear separating planes in the original space.
3.2.1 Linearly separable data
The simplest SVM is linear and trained on linearly separable data. Suppose we
have a training set of l examples, {xi, yi} where all yi ∈ {−1,+1} and xi ∈ Rd.
The form of an equation that separates the class of points with yi = 1 from
the class of points with yi = −1 is wTxi + b = 0. In this equation w is a weight
vector and b is a bias. wTxi + b ≥ 0 if yi = +1 and wTxi + b < 0 if yi = −1.
We call g given by
g(xi) = w
Txi + b
the discriminant or decision function. Points for which the discriminant func-
tion is 1 are called support vectors.
Since the data is linearly separable we can find a plane such that g(xi) ≥ +1
for yi = +1 and g(xi) ≤ −1 for yi = −1, this can be summarized as yig(xi) ≥ 1.
This may require scaling of w and b.
The shortest distance from the hyperplane to the closest positive example
is d+, and for the closest negative example d . The “margin” of the hyperplane
is d+ + d . These ideas are illustrated in figure 3.2.
We now would like to know what the distance of xi is to the hyperplane.
Suppose xp is the normal projection of xi on the hyperplane and d is the
desired distance, see figure 3.3. We can see xi = xp + d
w
||w|| . Then g(xi) =
g(xp + d
w
||w|| ) = w
Txp + b+ d
||w||2
||w|| = 0+ d||w|| = d||w||. Since support vectors
have |g(xi)| = 1, we have g(xi) = d||w|| = 1 for those points. So d = 1||w|| and
the margin is 2||w|| .
This means we can maximize the margin between the two classes by mini-
mizing:
1
2
||w||2, such that yi(wTxi + b) ≥ 1,∀i
Support vectors are of particular importance, since the solution would be
the same if all non-support vector points were removed.
This constrained optimization problem has a Lagrangian formulation, which
in turn satisfies the criteria to allow a “dual” formulation. The goal becomes
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Figure 3.2: Geometric interpretation SVM.
Figure 3.3: Distance to hyperplane.
30 CHAPTER 3. MACHINE LEARNING BACKGROUND
Figure 3.4: Soft margin SVM.
to maximize over the αi’s:
l∑
i=1
αi − 1
2
l∑
i=1
l∑
j=1
αiαjyiyjxixj , such that αi ≥ 0,
l∑
i=1
αiyi = 0
The weights can be retrieved from the Lagrange multipliers αi and the data
set, since w =
∑l
i=1 αiyixi. A crucial advantage of this formulation is that the
data only occurs in the form of dot products.
3.2.2 Non-linearly separable data
The constraints yi(w
Txi + b) ≥ 1 do not allow points to occur beyond the
borders of the margin. To soften these constrains, slack variables ξi are in-
troduced. The constrains become yi(w
Txi + b) ≥ 1 − ξi and we require all
ξi ≥ 0. This situation is illustrated in 3.4. To discourage situations with many
misclassifications, the goal becomes to minimize:
1
2
||w||2 + C
l∑
i=1
ξi, such that yi(w
Txi + b) ≥ 1− ξi, ξi ≥ 0∀i
Again a Lagrangian and its dual can be formulated. We should maximize:
l∑
i=1
αi − 1
2
l∑
i=1
l∑
j=1
αiαjyiyjxixj , such that 0 ≤ αi ≤ C,
l∑
i=1
αiyi = 0
Note that the only difference with the linearly separable case is the upper
bound on the αis. In this case a distinction is made between two types of
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support vectors. Bounded support vectors have αi = C. Non-bounded support
vectors have 0 < αi < C.
From optimization theory we can state a number of conditions, known as the
Karush-Kuhn-Tucker conditions, that are necessary and sufficient for w, b and
the αis to be a solution to this optimization problem. Some of those conditions
are that all ξi(αi − C) = 0. This means all non-bounded support vectors will
have ξi = 0. Therefore the non-bounded support vectors are located exactly on
the margin boundaries. It should be noted the complete set of Karush-Kuhn-
Tucker conditions also allows us to calculate the b in the decision function.
3.2.3 Non-linear SVM
Until now we had a situation where the decision function is a linear function
of the data. For some classification problems this approach may not be very
suitable. The approach taken in SVMs is to map the data from the input
space into another space (feature space), by a function φ(xi). If we find a
linear hyperplane in the feature space, this may correspond to a non-linear
hyperplane in the input space. This approach can of course also be applied to
other simpler classifiers such as k-nearest neighbors.
The advantage of SVMs is that the data occurs only as dot products in
the optimization problem. This allows the use of kernel functions K(x, y) that
are by definition < φ(x), φ(y) > for some φ. We do not need to specify φ
explicitly, which allows the mapping to very high dimensional spaces, or even
infinite dimensional spaces, for instance by using a Gaussian kernel (K(x, y) =
e−
||x−y||2
2σ2 ).
So our goal becomes to maximize:
l∑
i=1
αi − 1
2
l∑
i=1
l∑
j=1
αiαjyiyjK(xi, xj), such that 0 ≤ αi ≤ C,
l∑
i=1
αiyi = 0
Fortunately we do not require w (which is in the feature space) for the
decision function and end up with only dot products again:
f(x) = sign(
l∑
i=1
αiyiK(xi, x) + b)
3.3 Clustering by hierarchical clustering
In hierarchical clustering a binary tree is formed [15]. This is usually done
“agglomeratively”. Initially each example forms a separate cluster. Then it-
eratively the two closest clusters are connected to a new parent node which
together forms a new cluster, until the tree is complete. This procedure is
outlined in figure 3.5.
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Hi e r a r c h i c a l c l u s t e r i n g
Put each example in a separa te t r e e ( c l u s t e r )
Repeat un t i l one t r e e remaining
S e l e c t ‘ ‘ c l o s e s t ’ ’ pa i r o f t r e e s
Connect r oo t s o f those t r e e s to new root node
End repeat
Figure 3.5: Outline hierarchical clustering.
Figure 3.6: Typical output hierarchical clustering.
The distance between clusters is based on the distance between individual
examples. Some methods look at the set of distances between each pair of
examples, where each example is from a different cluster. “Single linkage”
takes the minimum of the set as cluster distance. “Complete linkage” takes
the maximum. “Average linkage” takes the average distance over pairs in the
union of both clusters.
The distances as obtained by the different linkage methods can be described
more formally. Consider X and Y to be sets of examples that occur in sep-
arate trees. The single linkage distance between X and Y is min{d(x, y)|x ∈
X and y ∈ Y }. Their complete linkage distance is max{d(x, y)|x ∈ X and y ∈
Y }. Finally the average linkage distance is mean{d(x, y)|x ∈ X and y ∈ Y }.
To measure the distance between the pairs of examples, any metric will do.
The measure chosen depends on the application. Popular choices include the
Euclidian distance, and 1− r, where r is the Pearson correlation coefficient of
the two examples.
Figure 3.6 shows a typical tree or dendrogram produced by hierarchical
Figure 3.7: Forming clusters from the dendrogram.
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Wrapper Feature S e l e c t i o n Algorithm
Repeat un t i l t e rminat ion c r i t e r i o n i s met
S e l e c t f e a tu r e s e t
Test f e a tu r e s e t using l e a r n i ng method
End repeat
Figure 3.8: Outline wrapper feature selection algorithm.
clustering. The position where two clusters are joined depends on the distance
between the clusters.
Figure 3.7 illustrates how the dendrogram can be used to obtain a true
clustering. A threshold is chosen thus dividing the large tree in several smaller
trees. The examples in each tree form a separate cluster.
3.4 Feature selection by wrapping
In general feature selection selects the relevant features from the data to de-
scribe the target concept. So it is a reduction of the dimensionality of the
data.
There are many approaches in machine learning and statistics that can
be thought of to perform some kind of feature selection. For instance, deci-
sion tree learning has some implicit feature selection. Unfortunately decision
trees are not very well capable of dealing with continuous attributes. Principle
components analysis (PCA, [20]) constructs features as linear combinations of
variables in the data in such a way that only a small number of those fea-
tures are required to describe the target concept. Unfortunately, in the data
sets used in this thesis the variables correspond to well defined biological con-
cepts like, pieces of chromosomal DNA, genes and proteins. The variables have
a clear biological interpretation. Linear combinations of those variables are
much harder to interpret. PCA does not clearly include or exclude features, it
assigns a weight to them.
For the tasks addressed in this thesis neither of the previous examples are
very suitable. In this thesis the problems have continuous variables and the
results should have a clear biological interpretation. The examples do indicate
there is a great variety of possible approaches to feature selection.
An important distinction can be made between so called “wrapper” and
“filter” methods. The wrapper approach of feature selection uses a search
algorithm to identify candidate subsets and the actual learning method is used
as a “black box” to evaluate the quality of the subset. The filter method does
not use the actual learning method to select the features. In this thesis emphasis
is on wrapper methods. The most general outline of a wrapper algorithm is
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given in figure 3.8.
When developing a wrapper method an important question is how to move
through the search space. Possible approaches are to start with one feature and
iteratively add one new feature. This is called “forward selection”. Another
way is to start with all features and iteratively remove one. This is called
“backward elimination”.
Another question is how to structure the search. An exhaustive search
may not be possible. There are many possibilities, like a greedy approach
that never reconsiders a choice when using one of the above mentioned search
space traversal strategies. Another method is called “stepwise” selection or
elimination. At each decision point you consider to remove or add a feature.
Best first search may also be possible.
Furthermore a stopping criterion for the search is required. Within wrapper
approaches the algorithm can stop if none of the feature sets that are considered
for the next iteration is an improvement.
Chapter 4
Noise reduction in array
CGH
4.1 Introduction
Array CGH is an approach for genome-wide measurement of aberrations in
chromosomal copy numbers. As mentioned in chapter 2, normal human cells
contain two copies of each of the 22 non-sex chromosomes (autosomes). In
tumor cells one or both copies of parts of chromosomes may be deleted or
duplicated. Chromosomal copynumbers are defined to be 2 for normal cells, 1
or 0 for single and double deletions and 3 and higher for single copy gains and
higher level amplifications.
The goal of the array CGH technique is the detection of DNA sequence
copy number changes and determination of the associated breakpoints along
the chromosomes. In other words, the purpose of array CGH is to construct a
graph of the copynumbers for a selection of clones (small pieces of DNA) as a
function of position of the clone on the genome.
DNA copynumber aberrations are used in cancer research, for instance, by
searching for novel genes implicated in cancer by analyzing those genes located
in regions with abnormal copy numbers. It is therefore of fundamental relevance
to identify as precisely as possible chromosomal regions with abnormal copy
numbers.
Because chromosomal DNA copy numbers for technical reasons cannot be
measured directly at high resolution, DNA from test cells is directly compared
to DNA from normal cells, using several thousands of small DNA fragments,
with known identity and genomic position (frequently referred to as clones or
BACs), as probes. Every single experiment yields tumor to normal ratios for
each clone on the array, and thus for each chromosomal location (see [47]).
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4.1.1 Array CGH experiments
In this section we will formalize a simple model of an array CGH experiment.
This should allow us to better understand some of the difficulties involved in
this type of experiments.
The outline of the array CGH procedure is as follows. Because copy numbers
cannot be measured directly, tumor cells are compared to normal cells. A large
number (thousands) of clones of different genomic positions are printed on
spots on a glass slide (micro-array), which is next treated with a mixture of
DNA originating from tumor and normal cells, both labeled and divided into
fragments. Before applying the DNA mixture to the micro-array the two types
of DNA are labeled red (Cy5) and green (Cy3), respectively. The labeled
fragments hybridize (“stick”) to a spot on the array with a matching DNA
sequence. The measured red/green ratio for each of the spots on the array is
roughly proportional to the quotient of copy numbers for tumor and normal
tissue. This experiment is repeated for a number of tumors. Below a more
elaborate treatment of the procedure is given.
A sample of cells taken from a tumor will generally consist of multiple cell
types, which may differ in their chromosomal copy numbers. In particular,
the sample usually consists of tumor cells and admixed normal cells. In some
cases the sample may also contain tumor cells that are intermediate in the
development of the tumor. Suppose the tumor sample consists of T different
cell types. Each of the T cell types has a certain copy number for each of the n
chromosomal locations measured. We call the copy number xij , where i is the
cell type and j the genomic position. Suppose that the chromosomal material
of Ni cells of type i is used in the experiment.
Suppose that in the experiment M reference cells are used. Obviously,
the reference cells are normal cells that have copy number 2 for all genomic
positions.
The micro-array contains a number of spots (can be thousands) that each
corresponds to a specific genomic position. Each spot contains a number of
pieces of identical cDNA, called clones. Suppose that each spot contains Hj
clones. This number depends on the particular spot, because there may be a
slight variation in the weight of the material put on the spot. Below we will
provide more details of the experiment.
The tumor and reference DNA is cut into small fragments and labeled.
Suppose all fragments have about an equal length of lf . Furthermore suppose
all clones of all spots have about an equal length lc. That gives
∑T
i=1
Nixij lc
lf
fragments of tumor DNA that could correctly fit a clone of spot j. There are
2Mlc
lf
fragments of reference material that can correctly fit to spot j. Obviously
some fragments cannot fit correctly to any clone, because the genomic position
of that fragment is not measured.
The tumor fragments are labeled red (with the Cy3 molecule). The reference
fragments are labeled green (with the Cy5 molecule). This labeling may not be
equally successful for the Cy3 and Cy5 molecules. The Cy3 and Cy5 molecules
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will attach to the Cs in the fragments. Suppose that r is the fraction of Cs
that gets labeled with Cy3 and g the fraction that gets labeled with Cy5.
After the labeling the fragments are put on the micro-array. It is assumed
an equal weight of fragments of tumor and reference samples is used on the
spots. So the actual number of cells used is not known. This introduces a
problem. For example, if all chromosomes of all tumor cells have copy number
four, we cannot distinguish them from those of normal cells, because simply
half the amount of tumor cells would be used in the experiment giving an equal
weight.
Not all fragments that could correctly hybridize to a specific clone type
actually do. Some of them will be washed of at the end of the experiment.
Suppose a fraction fs does correctly hybridize. This fraction is thus assumed
to be independent of the clone type or the difference in Cy3 or Cy5 labeling.
This gives rHjfs
∑T
i=1
Nixij lc
lf
tumor fragments that will correctly hybridize.
There are gHjfs
2Mlc
lf
reference fragments that correctly hybridize.
It should also be noted that the Cs may actually not be uniformly dis-
tributed over the genome. Suppose there are cj Cs in location j. This would
give rcjHjfs
∑T
i=1
Nixij lc
lf
labeled C’s of tumor fragments hybridized to spot j.
There are gcjHjfs
2Mlc
lf
such Cs in the reference.
Furthermore there are some fragments that will “cross hybridize”, that is
hybridize to a random genomic position. This is caused by the fact that there
are some sequences on the genome that are somewhat similar. Suppose for all
spots we find a number of such fragments with in total wj labeled Cs for both
the tumor and reference samples. This number may depend on the genomic
location, because not all locations may have an equal amount of similar enough
other regions on the genome to cause cross hybridization.
On the spots we can measure the red/green intensity ratio, which would be:
rcjHjfs
∑T
i=1
Nixij lc
lf
+ wj
gcjHjfs
2Mlc
lf
+ wj
If we assume almost no cross hybridization, this reduces to:
r
∑T
i=1 Nixij
2gM
If we assume there is one cell type that is by far most common we can
reduce this even further to
rnxj
2gM
.
One of the reasons why it is good to perform these experiments relative to
a normal reference is that the value for a particular spot becomes less sensitive
to the amount of material on the spot (Hj). Another reason may be that it
makes the values less sensitive to the distribution of Cs over the genome (cj).
Finally, the effect of cross hybridization is reduced to a linear scaling problem.
It is important that genomic locations measured within one experiment are
directly comparable to each other.
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From the previous elaboration it seems the array CGH ratios should be
proportional to the actual copy numbers. The CGH scale between different
experiments may vary due to the n, M , H, r, g, cj , fs and w, based on
this model. Estimating these variables is complicated since in many cases
chromosomal positions are not repeated on different spots. It should be noted
this model is very limited and is intended to illustrate some of the peculiarities
of array CGH data. There may be many more experimental factors involved.
A common way to scale is to divide by the median measured ratio. In the
sections about smoothing and clustering of experiments we will assume the
ratios are normalized in this way (sometimes also log transformed).
4.2 Smoothing
“Smoothing” refers to the process that adjusts the observed array-CGH values
such that they represent the copy number of the most common tumor cells.
That is, the algorithm tries to set the values to the means of the “clouds” of
points that are visible from the array CGH plots. Since the copy number of
a clone is always quite small (normally 2, varying from 0 to about 10), we
would like to set means of “clouds” that are close to the same value, because
they represent the same copy number. Next we also want the number of value
changes (“breakpoints”) to be small.
4.2.1 Algorithm
The problem can be formalized as model fitting to search for most-likely-fit
model given the data. A model describes a number of breakpoints, a position
for each, and parameters of the distribution of copy number for each. Then one
has to estimate the real parameters of the model from the observed array-CGH
values.
We assume that the data are generated by a Gaussian process and use the
maximum likelihood criterion for measuring the goodness of a partition, ad-
justed with a penalization term for taking into account model complexity. We
introduce a local search procedure that searches for a most probable partition
of the data using N breakpoints, for a given N . The procedure is incorporated
into a genetic algorithm that evolves a population of partitions with possibly
different number of breakpoints that may vary during execution. We design two
algorithms based on this approach. The first one is a genetic local search algo-
rithm that iteratively selects two ‘good’ chromosomes, generates two offspring
using uniform crossover, applies mutation and the local search procedure to
the offspring and replaces the worst chromosomes of the population with them.
The second algorithm generates only one offspring, applies local search and
tries to further optimize the offspring with an ad-hoc procedure.
We analyze the performance of these algorithms on array-CGH measure-
ments for 9 gastric cancer tumors. For each chromosome of a tumor, we com-
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LS
{
Take random se t o f breakpo int s among chromosomal p o s i t i o n s
While f i t t e r s e t o f breakpo int s can be found
{
For a l l b reakpo int s ( in random order )
{
Move breakpoint one chromosomal p o s i t i o n to l e f t
(or r i g h t by f l i p p i n g co in )
I f s e t o f breakpo int s becomes f i t t e r
{
Keep new s e t o f breakpo int s
Star t while loop again
}
Move breakpoint one chromosomal p o s i t i o n to r i g h t
I f s e t o f breakpo int s becomes f i t t e r
{
Keep new s e t o f breakpo int s
Star t while loop again
}
}
}
}
Figure 4.1: Outline LS algorithm.
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SA
{
Take random se t o f breakpo int s among chromosomal p o s i t i o n s
While f i t t e r s e t o f breakpo int s can be found
{
For a l l b reakpo int s ( in random order )
{
Move breakpoint one chromosomal p o s i t i o n to l e f t
(or r i g h t by f l i p p i n g co in )
I f s e t o f breakpo int s becomes f i t t e r or random accept
{
Keep new s e t o f breakpo int s
Star t while loop again
}
Move breakpoint one chromosomal p o s i t i o n to r i g h t
I f s e t o f breakpo int s becomes f i t t e r or random accept
{
Keep new s e t o f breakpo int s
Star t while loop again
}
}
}
}
Figure 4.2: Outline SA algorithm.
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pare the smoothing of the two GAs, the multi-start LS and the multi-start SA
algorithm. The LS algorithm is outlined in figure 4.1. The SA algorithm is
outlined in figure 4.2. Both algorithms are explained in more detail later. The
best algorithm we compare with the expert.
4.2.2 Breakpoint detection
In the used CGH experiments copy numbers are measured for approximately
2200 clones spread along the genome. We apply our algorithm to each of the
23 chromosomes separately. Denote by x1, ..., xn the measured CGH values
for a given chromosome. The main goal is to cluster these values in a small
number of clusters (x1, ..., xy1), (xy1+1, ..., xy2), ..., (xyN+1, ..., xn) such that the
copy numbers of the clones in each cluster are identical. We refer to the indices
y0 = 0 < y1 < ... < yN < n = yN+1 as breakpoints.
Our algorithm is motivated by the working hypothesis that the measured
value xj is equal to the relative copy number of clone j plus random noise that is
independent across clones. Thus our model stipulates that for yi−1 < j ≤ yi the
observed CGH value xj can be considered as drawn from a normal distribution
with mean µi and variance σ
2
i particular to the ith cluster. This leads to the
likelihood function
y1∏
i=1
1
σ1
√
2pi
e
− 1
2
“
xi−µ1
σ1
”
2
...
n∏
i=yN+1
1
σN+1
√
2pi
e
− 1
2
“
xi−µN+1
σN+1
”2
The maximum likelihood estimators are the parameter values for which this
expression is maximal. Given breakpoints y0 = 0 < y1 < ... < yN < n = yN+1
the maximization relative to the µi and σ
2
i is equivalent to performing max-
imum likelihood estimation on each of the samples xyi−1+1, ..., xyi separately,
which leads to the usual estimates
µˆi =
1
yi − yi−1
yi∑
j=yi−1+1
xj
and
σˆ2i =
1
yi − yi−1
yi∑
j=yi−1+1
(xj − µˆi)2
Reinserting these values into the likelihood we are, after some simplification,
left with
1
σˆy11
√
2pi
y1 e
− 1
2 ...
1
σˆn−yNN+1
√
2pi
n−yN
e−
1
2
The next step is to find suitable breakpoints by maximizing this relative
to y1, ..., yN . Equivalently, we minimize minus the logarithm, which up to an
additive constant is equal to
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Figure 4.3: Normal probability plots [52]
N+1∑
i=1
(yi − yi−1) log σˆi
Note here that the σˆi in this expression also depend on the choice of
y1, ..., yN . However, it is obvious that the highest value of the likelihood is
obtained by choosing the highest possible number of breakpoints, as this gives
more flexibility in choosing the parameters µi and σi. The last minimization
step is therefore not well defined. We remedy this by adding a penalty to
the criterion, in order to discourage a large number of breakpoints. A sim-
ple penalty of the form λN , for λ a suitable constant, performed well in our
experiments. This leads to the following function to be minimized.
f(y1, ..., yN ) =
N+1∑
i=1
(yi+1 − yi) log σˆi + λN (4.1)
If we consider there to be 3N parameters (2N continuous parameters and
N breakpoints), then the choices λ = 3
2
log n and λ = 3 correspond to Bayesian
information criterion [57] and Akaike information criterion [1], respectively. In
our experiments the choice λ = 10 was appropriate.
The assumptions of normality and independence may be slightly violated, as
illustrated by the normal probability plots [52] in figure 4.3 (data are normally
distributed when they lay near the dashed line). This holds also for normal
tissues, as shown by the plot in figure 4.4.
Nevertheless, in our experiments the resulting criterion gives adequate re-
sults.
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Figure 4.4: Normal probability plots [52]
4.2.3 The genetic / local search algorithms
The local search algorithm takes as input the CGH data l = x1, ..., xn of one
chromosome, a number N of randomly generated indices y1, ..., yN ∈ [1, n]
indicating potential (locations of) breakpoints, and updates repeatedly the
breakpoints (locations) in order to minimize the function f given in (4.1),
where the first term is the negative log-likelihood of the data and the second
one is a penalization with parameter λ which penalizes partitions containing
many breakpoints. The algorithm uses f as scoring function. At every iteration
an update rule is applied to each breakpoint, selected randomly. The update
rule chooses randomly a direction (left or right) and moves the breakpoint
location of one position in that direction only if the move improves the scoring
value (that is if f decreases), otherwise it moves the breakpoint of one place
in the opposite direction if this yields an improvement. The iterative process
terminates when the application of the update rule to each breakpoint does
not improve the scoring. We call this algorithm LS. We use LS in a multi-start
local search algorithm, and as local optimizer in the two heuristic algorithms
described in the sequel.
Genetic local search algorithms, also called memetic algorithms [38], use
local search for optimizing the population after or during the application of
the genetic operators. So at each iteration of the evolutionary process the
population consists of a set of local optima. We introduce the two memetic
algorithms illustrated below for identifying breakpoints in array-CGH data of
a chromosome, called GLS (figure 4.5) and GLSo (figure 4.6), respectively.
In order to avoid confusion, in the sequel we say “individual” instead of the
standard genetic algorithms term “chromosome” for indicating an element of
the population.
Our genetic algorithms use a representation where an individual is a bit
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GLS
{
generate i n i t i a l populat ion
while ( te rminat ion c r i t e r i o n not s a t i s f i e d )
{
s e l e c t two parents from populat ion using r o u l e t t e wheel
generate o f f s p r i n g using uniform c ro s s ov e r
apply mutation to each o f f s p r i n g
apply LS to each o f f s p r i n g
r ep l a c e two worst i n d i v i d u a l s o f populat ion with o f f s p r i n g
}
}
Figure 4.5: Outline GLS algorithm.
GLSo
{
generate i n i t i a l populat ion
while ( te rminat ion c r i t e r i o n not s a t i s f i e d )
{
s e l e c t two parents from populat ion using r o u l e t t e wheel
generate o f f s p r i n g using OR cro s s ov e r
apply LS to o f f s p r i n g
apply JOIN to o f f s p r i n g
r ep l a c e worst i nd i v i dua l o f populat ion with o f f s p r i n g
}
}
Figure 4.6: Outline GLSo algorithm.
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string denoting chromosome locations with a 1 in each location containing a
breakpoint and a 0 elsewhere. To maximize the fitness function, the score
function (4.1) has to be minimized, i.e. best fitness equals minimal score. The
initial population is constructed as follows. For each N in a fixed range, a
number k of elements is generated, where an element is a bit string with N 1’s
randomly placed. The local search LS is applied to each individual.
GLS uses (blind) uniform crossover, while mutation randomly decides whether
to add or remove a breakpoint and then applies the chosen operation (that is
flipping the value of the selected individual location). The “remove” operation
consists of removing the breakpoint that yields the best fitness. Note that this
operation is applied even if it does not improve the fitness of the individual.
The “add” operation selects the segment (a region between two consecutive
ones) with relative chromosomal array-CGH region (set of clones values) hav-
ing the highest standard deviation, and places a breakpoint in the middle of
that region.
The termination criterion is satisfied when either a maximum number of
iterations is reached or when the score of the best individual does not decrease
(or, equivalently, its fitness does not increase anymore) and there is no pair of
corresponding clones in the population having a difference in smoothed value
of more than 0.01. The smoothed value of a clone is the mean value of the
(chromosomal array-CGH region corresponding to the) segment containing that
clone.
GLSo generates one offspring per iteration by selecting two individuals and
constructing one offspring by taking the union of their breakpoints (by per-
forming a bitwise OR of the two individuals). Then the offspring is optimized
using LS and further optimized by removing breakpoints using the JOIN pro-
cedure. The JOIN procedure repeatedly selects the breakpoint whose removal
yields the biggest improvement (decrease) of the fitness function, and continues
until the fitness does not decrease anymore.
4.2.4 Experimental results
Genomic DNA was isolated from snap-frozen tumor samples taken from gas-
trectomy specimens. The samples were obtained from the archives of the de-
partment of Pathology of the VU University Medical Center. Array-CGH ex-
periments were performed according to [60] and ratio measurements according
to [24]. The scanning array comprised DNA from 2275 BAC and P1 clones
spotted in triplicate, evenly spread across the whole genome at an average
resolution of 1.4 Mb. Chromosome X-clones were discarded from further anal-
ysis since all tumor samples were hybridized to male reference DNA, leaving
2214 clones per array to be evaluated. Each clone contains at least one STS
(“sequence-tagged site”, a unique DNA sequence of a few hundred base pairs
long) for linkage to the sequence of the human genome. These data are analyzed
in [68].
The 9 tumors used to test our method are all gastric tumors. A manual
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Algorithm Median Mean
mLS -192.99 -218.77
mSA -193.29 -220.07
GLSo -194.47 -220.83
GLS -196.00 -223.08
Table 4.1: Mean and median fitness values for all algorithms. (Smaller is better)
smoothing for these tumors, carried out by the expert B. Ylstra, is used to
assess the performance of the algorithms and the maximum likelihood function
as approximation for the expert. We run our algorithms on each chromosome
of these 9 tumors, for a total of 207 chromosomes containing an average of
about 100 clones.
The following GA parameter setting is chosen. The initialization generates
40 individuals containing N breakpoints, with N that varies from 1 to 10.
An individual with 0 breakpoints is also added, thus giving a total of 401
individuals. The maximum number of local searches allowed is 100000. The
crossover rate equals 1. A single bit mutation is always applied.
The multi-start LS performs 100000 plus 1 local searches, where the number
N of breakpoints varies from 1 to 20, with an equal number of runs assigned to
each value of N . Also a run with 0 breakpoints is done. The final result is the
solution with best score over the runs. Note that the number of local searches
is kept equal, to make a fair comparison.
We compare the performance of GLSo, GLS, multi-start LS, and a multi-
start variant of LS based on simulated annealing (SA). The annealing schedule
of SA is as follows. The starting temperature is chosen to be 100000 (105).
Furthermore, it is chosen that after 10000 (104) changes of breakpoint location
the temperature should cool down to 0.00001 (10−5). This implies that after
each change the actual temperature is divided by 1010
−3
, since 10
5
x10
4 = 10−5 ⇒
x10
4
= 10
5
10−5
⇒ x104 = 1010 ⇒ x = (1010)10−4 ⇒ x = 1010−3 . After 10000
changes we make the algorithm behave exactly like LS. The other settings are
similar to the multi-start LS, except that it only performs 2001 runs to make
the comparison fairer in terms of computation time. The SA algorithm is
outlined in figure 4.2, where “random accept” means that a set of breakpoints
is accepted with a probability inversely proportional to the temperature.
We compare the performance of the four algorithms in minimizing the func-
tion (4.1) by the median and mean fitness values obtained for the 9× 23 = 207
chromosomes in our gastric tumors. In table 4.1 mLS and mSA denote multi-
start LS and SA, respectively. As shown in table 4.1 method GLS performs
best according to this criterion followed by the second genetic algorithm GLSo.
At closer inspection the nature of the differences in performance of the four
algorithms vary considerably over the 207 chromosomes. For 22 chromosomes
all four algorithms yield an identical smoothing, and for as many as 76 chro-
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Algorithm Median Mean Trimmed Mean # Zeros P-value
mLS-mSA 0.00 1.30 0.52 67 0
mLS-GLSo 0.00 2.06 0.22 50 0.63
mLS-GLS 0.70 4.31 1.84 81 0
mSA-GLSo 0.00 0.76 -0.08 31 0.47
mSA-GLS 0.79 3.01 1.66 62 0
GLSo-GLS 0.24 2.25 1.50 48 0
Table 4.2: Differences fitness values for all algorithms
mosomes the smoothings produced by at least three of the four algorithms are
identical. For this reason we also investigated the differences in fitness for the
207 chromosomes for each pair of algorithms. Medians, means, 20% trimmed
means, and the number of chromosomes with identical smoothing are given in
table 4.2, together with the p-values of the sign test. The latter test (cf. [52])
indicates if the observed differences (in obtained fitness values) between the
pairs of algorithms are statistically significant, under the assumption that the
207 chromosomes can be considered a random sample of chromosomes.
From these numbers we conclude again that GLS is best, followed by GLSo,
mSA and mLS. Furthermore, the superior performance of GLS is statistically
significant, whereas the observed differences between the other methods may
not be replicable on data of additional tumors.
To illustrate the results of the four algorithms we show pictures (figure 4.7)
of the smoothing/breakpoints found by each of algorithms on one of the tumors
in which various types of chromosomal aberrations (gain, loss and amplifica-
tion) occur.
In order to assess the convergence behavior of the genetic algorithms we give
plots (figure 4.8) of a typical histogram of the distribution of breakpoints within
the solutions of the pool after the stopping criterion is satisfied. The plots
indicate that the evolutionary process ends with individuals with breakpoints
in nearby locations. Observe that the stopping criterion is such that shifting
a breakpoint within an area that has no clear breakpoint stops the iterations.
In such a case there is “no clear breakpoint”, meaning that the means of the
two corresponding segments in all individuals are close. This may cause the
algorithm to stop after a few iterations even if the individuals have breakpoints
in different locations.
Next, we compare the robustness of the genetic algorithms, that is the
sensitivity of the outcome to the initialization and other random operators used.
We plot a typical histogram (figure 4.9) of the location of breakpoints of the
best individual of the final population over 100 runs of the genetic algorithms
on chromosome 1.
Finally, we compare the smoothings and breakpoints obtained by GLS with
those manually produced by the expert. The manual smoothings have been
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(d) Tumor 2008c, dots are raw data, line is result of GLS
Figure 4.7: Illustration results all algorithms
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Figure 4.8: Distribution of breakpoints in pool after stopping criterion
0 50 100 150
0
10
20
30
40
50
60
70
80
90
100
(a) GLSo, tumor 2730, chrm 1
0 50 100 150
0
10
20
30
40
50
60
70
80
90
100
(b) GLS, tumor 2730, chrm 1
Figure 4.9: Distribution of breakpoints for best individual of final population
over 100 runs
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built under the assumption that there is a small number of different smoothing
levels, reflecting the observation that few copy number values are present in
chromosomes. In order to incorporate this constraint in our method, we per-
form a post processing step that joins close smoothing levels. To this aim the
k-means algorithm is applied to the set of CGH values generated by running
GLS over all the chromosomes of a tumor, and then the resulting smoothing
levels that are closer than a fixed threshold are joined. Over all tumors the
average difference between the values of the clones is 0.0513, indicating that
GLS followed by post processing (denoted below by GLS-pp) is a satisfactory
approximation of the manual smoothing. GLS seems more sensitive to outliers.
This can be explained by the fact that the expert sometimes knows an outlier
is meaningless and so ignores it. Figure 4.10 shows an example comparison
between our algorithm and an expert smoothing.
4.2.5 Discussion
The results of the experiments indicate that GLS performs better in minimizing
function (4.1) than the other algorithms.
Both GAs converge within the maximum number of iterations in case the
data contains clear breakpoints. The stopping criterion prevents the algorithm
from searching for optimal locations of breakpoints that are not clear.
GLS-pp finds smoothings that are very similar to the manual smoothings. It
should be noted that an expert produces smoothings based on more information
than just the CGH values. An expert also keeps in mind information like
misplacement of clones on the genome and recurring aberrations of clones due to
known experimental artifacts. From the normality plots shown it seems that the
final expert smoothings are reasonably well normally distributed. Lacking data
combining CGH values with known copy numbers in cell types and frequencies
of cell types in samples, we were not able to test the suitability of our model to
remove noise from the experiment and some cells of types that occur in small
numbers. This remains an open problem for future research.
4.3 Software
The ratios found in array CGH experiments have some noise generated by
polymorphic sites (sequence variation between individuals), some experimen-
tal noise as well as compression of the ratios due to aneuploidy and admixed
non-tumor cells. This noise renders the identification of breakpoints and the
determination of the true copy number values problematic. To facilitate and
standardize this process, aCGH-Smooth has been developed.
aCGH-Smooth is a tool for the automated identification of breakpoints
and smoothing of micro-array comparative genomic hybridization (array CGH)
data. aCGH-Smooth is written in visual C++, has a user-friendly interface
including a visualization of the results and user-defined parameters adapting
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(c) Tumor 2730, dots are the difference between GLS-pp and the manual smoothing
Figure 4.10: Illustration comparison manual and automatic smoothing
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the performance of data smoothing and breakpoint recognition. aCGH-Smooth
can handle array-CGH data generated by all array-CGH platforms: BAC, PAC,
cosmid, cDNA and oligo CGH arrays. The tool has been successfully applied
to real-life data.
The core of aCGH-Smooth is GLS-pp as explained previously. It identifies
potential breakpoints and smoothes the observed array CGH values between
consecutive breakpoints to a suitable common value.
The output of aCGH-Smooth is a mapping which associates to each clone
a new value. For every batch of experiments, aCGH-Smooth allows adapting
the settings for smoothing and breakpoint recognition to the requirements of
the raw data, depending on the biological and technical quality of the samples
analyzed.
aCGH-Smooth takes as input Excel files, e.g. the ones produced by, the
GenePix Pro software (Axon inc, CA), the UCSF Spot software [24] or Im-
agene (Biodiscovery Inc., El Segundo, CA). A file describes one array CGH
experiment, which includes a sequence of clone positions in the genome and
clone values measured in the experiment.
A novel option of aCGH-Smooth allows the user to set the value of a thresh-
old used for detecting potential amplicons and outliers. The corresponding
clones are not considered by the smoothing algorithm.
4.3.1 Results
We show the results of aCGH-Smooth with default parameters when applied
to three types of array-CGH experiments.
Figure 4.11 shows a gastric tumor experiment, performed at the UCSF
Cancer Center, with a CGH-array that has PCR representations of BAC and
PAC clones as a probe spotted on the array. Each spot on the array covers
around 100-200 kb of the human genome ([69]).
Figure 4.12 is a ”normal to normal” experiment, except that there is an
extra copy of chromosome 18. It was performed at the VU Medical Center
of Amsterdam. It uses CGH-arrays that have synthetically synthesized oligos
as a probe spotted on the array. Each spot on the array covers 60 bp of the
human genome. As can be seen from the figure, the line is not entirely straight
at all but one area, this may indicate very noisy data or a too small penalty
for inserting breakpoints.
Figure 4.13 shows a ”normal to normal” experiment, except that there are
3 copies of the X chromosome. It was performed at Stanford [49], and uses
CGH-arrays that have cDNAs as a probe spotted on the array. Each spot on
the array covers between 200 and 1500 bp of the human genome.
We found that only in few points there is a clear difference between the re-
sults given by aCGH-Smooth and by the expert. aCGH-Smooth can thus easily
and effectively be applied for data generated by different analysis programs and
different array-CGH platforms.
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Figure 4.11: aCGH-Smooth applied to a gastric tumor
Figure 4.12: aCGH-Smooth applied to oligo data
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Figure 4.13: aCGH-Smooth applied to Stanford data
4.4 Related work
Other methods/tools for array-CGH analysis based on different computational
approaches have been introduced at the time of or after the proposal presented
in this chapter. For instance, [17] which uses Hidden Markov Models (HMM)
for modeling the possible dependence of a clone with its near neighbor. In [41]
a variant of the binary segmentation approach is used. In [4] a procedure that
includes a moving average, k-means and dynamic programming is proposed.
[67] uses a hierarchical clustering method in combination with an estimate of
the false discovery rate.
Recently, an article appeared, comparing 11 different noise reduction ap-
proaches for array CGH experiments [31]. These include both segment detec-
tion methods and smoothing methods, based on diverse techniques as mixture
models, Hidden Markov Models, maximum likelihood, regression, wavelets, ge-
netic algorithms, and others. They compute the Receiver Operating Character-
istic (ROC) curves using simulated data to quantify sensitivity and specificity
for various levels of signal-to-noise ratio and different sizes of abnormalities.
They also characterize the performance of the algorithms on chromosomal re-
gions of interest in a real data set obtained from patients with Glioblastoma
Multiforme [31]. Although no strong conclusions were drawn, the approach
presented in this thesis successfully detected most of the (sometimes artificially
generated) aberrations.
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4.5 Future directions
The most obvious violations of the normality assumption are caused by ampli-
fications. Results can be further improved if the clones in amplification areas
are removed from the data. Amplifications are small areas on the genome with
a high copy number. The genes on those areas are important candidates to be
oncogenes. However, it is not easy to define an amplification unambiguously.
An amplification area starts with a “big” increase of CGH value, lasts for only
a “few” clones, after which the CGH values decrease “steeply”. The number of
clones for which an amplification “lasts at most” is a parameter. The increase
and decrease of the value that are at least necessary to form an amplification
depend on all value changes between consecutive clones. Say the average value
change is d and the standard deviation of the value changes is sd. Then the
criterion could be di−d
sd
≥ T , where T is a parameter.
Another subject that deserves attention is overlapping chromosomal po-
sitions. Since the number of spots on micro-arrays increases over time with
the technological developments, an increasing number of experiments where
chromosomal positions overlap can be expected. The overlapping regions may
provide valuable information about the amount of noise present in the experi-
ments.
Furthermore, it may be beneficial to gain more insight in the sources of
noise of the experiments, such as cross hybridization. Incorporating this type
of information into a smoothing algorithm could improve the performance.
However, obtaining information about, say, the “amount” of cross hybridization
may not be trivial.
From a broader perspective, noise reduced array CGH data can be valuable
in combination with RNA expression array data, to detect correlations between
gene expression and copy number levels.
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Chapter 5
Comparing CGH platforms
5.1 Abstract
A series of studies have been published that evaluate the chromosomal copy
number changes of different tumor classes using array Comparative Genomic
Hybridization (array CGH), however, the chromosomal aberrations that distin-
guish the different tumor classes have not been fully characterized. Therefore,
we used a meta-analysis of different array CGH data sets in an attempt to
classify samples tested across different platforms. As opposed to RNA expres-
sion array analysis a common reference is used in dual channel CGH arrays:
normal human DNA, theoretically facilitating meta-analysis. To this aim, cell
line and primary cancer data sets from three different dual channel array CGH
platforms obtained by four different institutes were integrated. Preprocessing
methods were developed, trained and optimized using cell line data. The pre-
processing performed noise reduction and transformed samples into a common
format. The transformed array CGH profiles allowed perfect clustering by cell
line, but importantly not by platform or institute. The same preprocessing
procedures used for the cell line data were applied to 373 primary tumors pro-
filed by array-CGH, including controls, to determine by clustering the degree
of separation of different tumor classes. Results indicated that there is no ap-
parent feature related to the institute or platform and that array-CGH allows
for an unambiguous genomics meta-analysis. Major clusters with common tis-
sue origin were identified. Tissue clusters were not pure, but interspersed by
tumors of different origin, likely reflecting a limited convolution of tumor origin
specific chromosomal aberrations.
5.2 Introduction
As stated in the previous chapter, array CGH is the high-resolution labora-
tory technique of choice for the detection of chromosomal DNA copy number
57
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ID Color Inst. Ref. Platform Tissue # Exp.
1 Stanford [49] cDNA Breast 44
2 UCSF [60] BAC Breast 2
3 VUMC Oligo Breast 20
4 Cambridge [13] BAC Colon 37
5 UCSF [39] BAC Colon 25*
6 VUMC BAC Colon 20
7 VUMC Oligo Colon 3
8 UCSF [59] BAC Fallopian 12
9 UCSF [68] BAC Gastric 36
10 VUMC BAC Gastric 20
11 UCSF [62] BAC Head and Neck 89
12 VUMC BAC Lymphoma 34
13 VUMC Oligo Lymphoma 3
14 UCSF [65] BAC Prostate 4
15 VUMC Oligo Retinoblastoma 5
16 Stanford [33] cDNA Soft tissue 25*
Table 5.1: Primary cancers. “ID” is an identifier that allows us to refer to all
studies. “Inst” gives the institute that manufactured the arrays. “Ref” gives
a reference for the previously published data. “Platform” provides the type of
spotted probes used. The column “Tissue” provides type of tissue. “# Exp”
gives the number of primary cancers collected. *) First experiments of larger
set.
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Figure 5.1: Hierarchical clustering of cell line experiments. The labels of the
experiments have 4 columns. From left to right they represent the cell line,
platform, institute and year. The year is only given for the UCSF platform,
2001 referring to [60] and 2003 referring to [61]. The red blocks mark experi-
ments on the same cell line. The colors in the dendrogram indicate the support
of the clusters; from complete to low support, black, gray, blue, green, yellow,
orange, purple and red.
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Figure 5.2: Hierarchical clustering of primary cancers. Column “A” shows the
controls. The green regions are the Lymphoma clusters mentioned in the text.
The arrows are the 3 Oligo lymphomas. The black bars are the three BAC and
Oligo pairs that cluster together. Column “B” indicates the two large colon
and breast cancer clusters. Column “C” is the dendrogram of the hierarchical
clustering. The colors in column “D” correspond to the colors found in Table
5.1. It indicates the distribution of the experiments from the various sets over
the clustering. To the right of the two columns is the primary cancer data. At
the bottom the chromosome numbers are shown. To the right of the clustering
two subclusters are highlighted. They are the main colon and breast cluster as
referred to in the text. In contrast to the remainder of the clustering it shows
the identifiers of each individual experiment.
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aberrations (see also [46]). We and others [2] hypothesize that driver genes de-
termine the location of aberrations. This would occur through clonal selection
during the development of the cancer. Thus amplifications or other chromo-
somal aberrations have a certain cancer specificity, which can be exploited in
a meta-analysis. For example, within a gastric cancer set we previously iden-
tified array-CGH signatures associated with different clinical outcome [68]. In
addition, array CGH revealed that more advanced, aggressive or metastatic
cancers often display more chromosomal aberrations [71]. This illustrates that
array CGH profiles reflect tumor characteristics.
A variety of commercial and non-commercial platforms for array CGH have
become available using bacterial artificial chromosomes (BACs), phage artificial
chromosomes (PACs), cosmids, cDNAs, fosmids, synthetic oligo-nucleotides
[46]. Several genome-wide array CGH studies, such as breast [49], fallopian
tube [59], prostate [65] and soft tissue cancers [33] have been published.
In this chapter we use meta-analysis of array CGH data from different plat-
forms and institutes. Such analysis is important since: it gives the possibility
to achieve more robust and reliable results by considering data sets from dif-
ferent studies, it offers the ability to perform relative analysis of samples from
different types of cancers, and finally it allows the identification of subgroups
of samples not only within a cancer type, but also within different types of
cancers. Such cross-cancer type patterns may show specific biological and / or
clinical features [70]. The main advantage of meta-analysis is that whenever a
new data set is generated, this data set can be compared to previously gener-
ated data sets. This will generate additional insights in the distinct features of
the newly created set, which emphasizes the relevance of meta-analysis.
Array CGH data from different platforms cannot be compared directly, since
each platform contains different numbers of clones at variable spacing and res-
olution, and the noise distributions varies across platforms [46] as well as the
amplitude for a given copy number change [6]. Finally, the way each institute
performs the experiments may introduce specific types of noise in the data
and influence dynamic range. We developed a five-step preprocessing method-
ology to overcome these problems. To test and optimize the performance of
the methodology we initially used cell line data obtained by different laborato-
ries using different platforms for the preprocessing and hierarchical clustering.
Subsequently, we applied the same procedure to primary cancer data from 373
samples. Array CGH data is less complex than expression array data, since
the data resulting from the chromosomal copy numbers that underlie the ra-
tios, are integers [30] and nearby chromosomal positions tend to have a highly
correlated CGH value. The use of a common reference of array CGH experi-
ments provides an intrinsic baseline, which is a big advantage for meta-analysis,
compared to RNA gene expression experiments.
62 CHAPTER 5. COMPARING CGH PLATFORMS
5.3 Material and methods
5.3.1 Data collection
We collected dual channel array CGH data sets that are publicly available
from cell lines and primary cancers. To obtain a reasonable number of data
sets while maintaining an overall high resolution, only those with a genome
wide average resolution of 1.5 Mb or higher were selected. Some cell lines were
used in experiments on different platforms at different institutes. The cell line
data sets contained 7 duplicates, 3 triplicates, 1 quadruplet and one cell line
was used 5 times (Table 5.2).
Dual channel array CGH profiles of 373 primary tumor samples were col-
lected that are either publicly available or performed in our laboratories. These
include either BAC arrays from the Sanger Institute in Cambridge (UK), the
University of California in San Francisco (UCSF) and our own laboratory in
Amsterdam (VUMC), or oligonucleotide arrays from our own laboratory or
cDNA arrays from Stanford University (Table 5.1).
A large set of BAC and Oligo array experiments were performed by us and
unpublished. VUMC BAC array CGH was performed according to the pro-
tocols described by [56]. VUMC oligo array CGH was performed essentially
according to [9] using the Human Release 2.0 oligonucleotide library, contain-
ing 60-mer oligonucleotides representing 28830 unique genes as designed by
Compugen (San Jose, CA, USA), and obtained from Sigma-Genosys (Zwijn-
drecht, The Netherlands). Oligo arrays were scanned using a laser scanner
(Agilent Technologies, Amstelveen, NL) and analyzed using Bluefuse Software
v.2.0 (Bluegnome Ltd, Cambridge, UK). For all VUMC arrays presented a
reference of pooled DNA samples from 10 healthy individuals was used.
5.3.2 Preprocessing data to transform samples into a com-
mon format
Preprocessing methods were developed and applied, which perform noise re-
duction and transform samples into a common format.
Clone mapping The May 2004 freeze of the UCSC, ENSEMBL and CHORI
databases was used. Clones not found in these databases were excluded.
Noise reduction To overcome the problem of varying noise across platforms
the array CGH smoothing algorithm was applied (chapter 4 and [29]). Smooth-
ing settings depend on the number of clones and noise profile, and therefore
on platform. Previously the settings for the BAC platform were adjusted by
expert opinion [30] which was applied here to the other platforms. The param-
eter λ in the smoothing algorithm, a value which is inversely proportional to
the number of breakpoints identified, was set to 2 for the Oligo platform, 1.5
for the cDNA, and 0.8 for the BAC.
Chromosomal position sampling To deal with the varying positions of the
different clones on the genome, 100 positions were sampled on each chromo-
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Tissue Cell Lines
Breast BT474 (a,b,c,d,e), MDA-MB-231
(b), MDA-MB-453 (b,e), MPE600
(b), T47D (a,b,e), SKBR3 (a,c,e),
MDA-MB-436 (b,e), CAL51 (e),
MCF7 (a,b,c,e), MDA-MB-134 (e),
MDA-MB-157 (a,e), MDA-MB-175
(e), MDA-MB-361 (a,e), MDA-MB-
415 (e), MDA-MB-468 (e), MT3 (e),
SKBR7 (e), SUM149 (e), SUM159 (e),
SUM44 (e), SUM52 (e), UACC812
(a,e), VP185 (e), VP229 (e), VP267
(e), ZR-75-1 (a,e), ZR-75-30 (a,e),
UACC893 (a)
Colon HCT116 (b,c,e), HT29 (b), SW837 (b),
DLD1 (c), LoVo (c), LS174T (c), SW48
(c)
Endometrium AN3CA (c), SKUT1 (c)
Prostate DU145 (c)
Leukemia Jurkat (c)
Ovarian SKOV3 (b,c)
Table 5.2: Cell line data sets. “Tissue” gives the tissue origin of the cell line.
“Cell lines” gives the name of the cell line and between brackets the platforms;
“a”, 10 cDNA experiments performed at Stanford University [48]; “b” 11 BAC
experiments performed at UCSF [60]; “c” 12 BAC experiments performed at
UCSF [61]; “d” 1 new BAC experiment performed at VUMC; “e” 27 New Oligo
experiments performed at VUMC.
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some at equal spacing. This approach weighs each chromosome equally and
emphasizes breakpoints over chromosomal length.
Interpolation The DNA copy number ratio for each sampled position was
set to the ratio of the closest position in the smoothed data.
Scaling The dynamic range for the CGH ratios may vary across platforms
such that a single copy gain in one platform gives a higher or lower value
compared to another platform [6]. One of the most notable differences between
DNA from cell lines and primary cancers is the purity of the samples. While the
chromosomal DNA of cell line samples is identical in nearly 100% of its cells,
cancer samples have different admixtures of cancer and normal cells. This
heterogeneity of samples results in cancer / reference ratios closer to one, or
equivalently log ratios closer to zero in primary cancer samples. Transforming
the smoothed log ratios to z-scores was used to reduce this effect. This means
that per experiment the average ratio was subtracted from all ratios and the
resulting ratios were divided by the standard deviation of the original ratios.
5.3.3 Meta-analysis procedures
Cell line data
The cell line data was used to optimize the preprocessing procedure proposed in
the previous section. Hierarchical clustering with the average linkage method
was then used for the analysis of array CGH data [62, 68]. To overcome scaling
problems we used the Spearman rank correlation distance [15, 53], since it is
scale independent.
The robustness of the clustering obtained with the cell line data was eval-
uated with the “support tree” method in TIGR MeV [18, 53]. This is a boot-
strapping method where chromosomal positions are randomly sampled with
replacement and the hierarchical clustering is performed again on these data.
This was done 100 times. A particular cluster that reappears frequently is
likely not to be biased by a small number of clones.
Secondly, we analyzed the amount of variance due to platform or institute.
This was done for each cell line and each sampled position by computing the
standard deviation at that position over all the experiments on that cell line.
Primary tumor data
We applied the same preprocessing steps used with the cell line data to the
primary cancer data, followed by a hierarchical clustering applied as above.
The settings were kept identical to those used for the clustering applied to the
cell line meta-data.
To determine the chromosomal positions that set clusters apart, the Wilcoxon
rank sum test was applied. Positions were selected that have significantly dif-
ferent median at the corrected 0.05 p-value level with Bonferroni correction.
Finally, we applied a linear support vector machine (SVM) to the significant
positions. This was done using a five-fold cross validation procedure, meaning
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the data set was randomly divided in five parts and to train five linear SVMs
each time leaving one part out. Each time the left over part was used as test
set, to estimate the generalization error. For the linear SVM the data was
scaled using z-scores per experiment before selecting the positions.
5.4 Results and discussion
5.4.1 Common cell lines to optimize meta-analysis set-
tings
Different array platforms use different type, length, mapping and number of
clones, different print pins and surfaces, different labeling and hybridization
procedures, different normal reference samples and DNA isolation procedures,
different scanning and imaging procedures etc. This results in profiles that rec-
ognize the chromosomal aberrations, yet differ in noise distribution, amplitude
and resolution (Figure 5.3).
As a first control of performance of the preprocessing steps a variance anal-
ysis was applied to the normalized meta-data set. The distribution of the
standard deviations is such that for each cell line at least 75
As a second method to test the preprocessing steps for the meta-analysis
we used hierarchical clustering. The dendrogram produced by the hierarchi-
cal clustering shows all experiments on the same cell line cluster together, not
interspersed by other cell lines (Figure 5.1). Interestingly, we also noted that
cell lines VP229 / VP 267 derived from a primary breast cancer and its re-
lapse, respectively, cluster together in the same terminal branch of the tree.
We therefore conclude that the cell line experiments cluster by copy number
characteristics rather than by platform or institute.
5.4.2 Clustering of primary cancers
Hierarchical clustering was applied to the primary cancer meta-data using the
same settings as used for the clustering of the cell line data. Internal con-
trols included 3 colorectal samples that were performed independently (differ-
ent days and technicians) on two different platforms, the VUMC BAC array
and the VUMC oligonucleotide arrays. A second set of controls included 37
lymphoma samples, all from the VUMC pathology department, of which 34
were hybridized to the VUMC BAC arrays and 3 to the oligonucleotide arrays.
In Figure 5.2 it can be seen that the 3 colon samples on the 2 different platforms
perfectly pair (Figure 5.2, black bars). Lymphomas fall in two main clusters of
5 and 15 and one mixed cluster containing 8 lymphoma samples (Figure 5.2,
green bars). The remaining 6 lymphoma samples are scattered throughout the
meta-cluster. The three lymphomas performed on the oligonucleotide arrays
(indicated by arrowheads) cluster either within one of the two main clusters
and one pairs separately together with another lymphoma sample. In addition,
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(a)
(b)
(c)
Figure 5.3: Comparison of array CGH on three different platforms by three
different institutes. The figures represent three BT474 cell lines with log trans-
formed CGH values after mapping to the same freeze, but before any other
preprocessing. The x-axis represents the chromosomes. The y-axis are the log
transformed CGH ratios. “a” is from [59], “b” from [48] and “c” is an Oligo
experiment performed at the VUMC.
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Figure 5.4: Platform dependent variation compared to variation in the different
cell lines. For each cell line a boxplot of the standard deviations of all sampled
positions over all experiments on that cell line is shown. The right-most boxplot
thus represents the variation due to the data, since it was constructed using
the entire cell line data set, whereas the other boxplots indicate the variation
due to the platforms and institutes. The box has lines at the lower quartile,
median, and upper quartile values. The whiskers are lines extending from each
end of the box to show the extent of the rest of the data. Outliers are data with
values beyond the ends of the whiskers. The whiskers end at 1.5 times the inter
quartile range. The dashed lines are drawn at the lower quartile of the boxplot
for the entire data set and at the largest upper quartile of the individual cell
lines.
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one large cluster containing the majority of colorectal samples (51) is apparent
(Figure 5.2, red bar), where samples profiled on BAC arrays from three differ-
ent institutes intermingle. The final proof that the meta-clustering is reliable
is provided by the primary breast tumor samples, which were performed on
three different platforms: cDNA, Oligo and BAC CGH arrays. One striking
meta-cluster containing 24 breast tumor samples from all evaluated platforms
can be recognized (Figure 5.2, blue bar).
In summary 4 controls produced the expected results. First, identical colon
samples on different platforms cluster perfectly together. Secondly, the lym-
phoma cases show that samples from one institute and same tissue origin but
profiled on different platforms cluster together. Thirdly, colon samples from dif-
ferent institutes on same platforms cluster together. Finally, the breast samples
show that samples from different institutes and the same tissue origin cluster
together. It can therefore be concluded that the meta-clustering is reliable
on primary tumor data, since samples cluster by cancer type rather than by
institute or platform in an unsupervised manner.
5.4.3 Analysis of large primary cancer clusters
The meta-analysis discerned major clusters with common tissue origin, the
clusters are interspersed by tumors of different origin. The large colon cluster
at the top is followed by the cluster with 8 lymphoma cases. Further down
the largest cluster of soft tissue cancers follows and a cluster of mixed colon
and gastric samples. Next cluster down is the breast tumor cluster mentioned
above. Next, small breast, retinoblastoma and head and neck clusters follow.
These clusters are all admixed with gastric samples. In this region we also find
the largest lymphoma cluster discussed above. Some smaller clusters, including
the third lymphoma cluster follow, ended by the largest gastric cluster of 11
samples and 3 bigger clusters of primarily head and neck origin.
The breast and colon clusters are the most informative clusters with respect
to the performance of meta-clustering. The breast cluster is the most striking,
since it represents arrays from all three platforms, BAC, oligo and cDNA and
the colon cluster represents BAC arrays from three different institutes.
To determine the chromosomal positions that discriminate the breast and
colon clusters a Wilcoxon rank sum test was used. Subsequently, a linear SVM
was applied to the significantly different positions. The error rates indicate
array CGH data can be used to discriminate between the colon and breast
cancer clusters using only the positions with significant difference in median
(table 5.3).
Distinct chromosomal areas emerge that discriminate the main breast clus-
ter from the large colon cluster (Figure 5.5). These areas correspond to 6
chromosomal regions, namely: 5q35.1-2 representing 5 consecutive positions of
the 100 chromosomal positions, 7p13 through 7p11.2 with 4 consecutive po-
sitions representing the 4 chromosomal bands closest to the centromere, the
entire chromosome 13, a large centromeric part of chromosome16p (16p13.13 -
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Mean (Std. dev.)
Error 0.014286 (0.031944)
Sens 0.980000 (0.044721)
Spec 1.000000 (0.000000)
Table 5.3: Breast cancer cluster (negative) and colon cancer cluster (posi-
tive) separated using only significantly different chromosomal positions. 5-fold
cross validated linear SVM. The first row is the error, which is the fraction
of misclassifications. The second row is the sensitivity, which is the number
of correctly positive classified experiments divided by the total number of ex-
periments classified as positive. The third row is the specificity, which is the
number of correctly negative classified experiments divided by the total number
of experiments classified as negative. The second column shows the error, sensi-
tivity and specificity of a 5-fold cross validated linear SVM. The reported error,
sensitivity and specificity are averages over the 5 runs and between brackets
are the standard deviations.
Figure 5.5: Genomic locations with significant difference in median between
the breast and colon cancer clusters (179 positions), tested with the Wilcoxon
test. The horizontal axis represents the chromosomes. The dots are present
at genomic locations that show a significant difference in median between the
groups.
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16p11.2, 28 clones), the majority of chromosome 18q (q12.2 - q23, 41 clones)
and 20q12 represented by only one clone. The identified chromosomal regions
confirm much of the known features of these types of tumors and are consistent
with many of the published array-CGH and cytogenetic studies. For example,
chromosome 20 is amplified in the majority of colon tumors [13, 39, 21, 50],
but only in 20% of breast tumors [2, 49]. Chromosome 7 is a typical feature of
many colon tumors, but not frequently detected in breast tumors [13, 39].
In conclusion, our meta-methods can be applied to detect the differences
between meta-clusters. Similarly, supervised methods can be used to detect
differences between tumors or tumor subtypes whereby array CGH platforms
can be intermixed, which is beyond the scope of this chapter.
5.5 Conclusions
The unsupervised meta-analysis of primary tumors reported here is the first
description of array-CGH-based cancer meta-clustering. We have shown un-
ambiguous meta-clustering of array CGH data from a selection of different
platforms and institutes. One of the advantages of array CGH as a genomics
array technique is that meta-analysis of array CGH is more straightforward to
perform as well as less ambiguous for interpretation compared to meta-analysis
of other types of genome wide data such as expression micro-arrays [37, 51]. We
conclude, based on the cell line data, the lymphoma, breast and colon controls
that platform effects are negligible. Figure 5.3 shows that all platforms have
a distinct noise distribution. Addressing this noise issue is not trivial and we
described here an algorithm that deals effectively with it.
Array CGH is a powerful technique that measures chromosomal copy num-
ber aberrations, but other genetic aberrations, such as small nucleotide poly-
morphisms [72], translocations, methylations [71] balanced translocations [42]
and copy number variations are not taken into account [58]. The ratios that
underlie array CGH thus result from chromosomal copy number aberrations
only, which are integers [33] and nearby chromosomal positions tend to have
a highly correlated CGH value [64]. Although some major clusters were iden-
tified, many tumors are scattered throughout, which may be explained by the
algorithms used for this meta-clustering, in which emphasis is put on larger
chromosomal regions, such that narrow specific amplifications, like the one for
Erbb2 in breast cancer [49], may be missed.
For the meta-clustering presented we have made a choice that represents a
balance between breakpoints and chromosome length and was justified by per-
formance in the cell lines. Other approaches and choices may lead to different
clustering, but that does not influence the quality of the meta-clustering as
presented here.
Much new information can be gained using meta-analysis, whenever a new
series of experiments are performed on whichever array CGH platform. For
example, the region 5q35.1-2 has not previously been noted as particularly
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important for breast or colon tumors [39], but judged from the meta-analysis
seems important to be considered as an important region for either breast or
colon carcinogenesis. The approach described here also opens the prospect of
using array-CGH meta-data for molecular classification of cancers from the
same site (for example, luminal versus basal types of breast cancer) and also
for clinical correlations.
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Chapter 6
Clustering micro-array data
6.1 Abstract
This chapter shows how clustering can be performed by using support vec-
tor classifiers and model selection. We introduce a heuristic method for non-
parametric clustering that uses support vector classifiers for finding support
vectors describing portions of clusters and uses a model selection criterion for
joining these portions. Clustering is viewed as a two-class classification problem
and a soft-margin support vector classifier is used for separating clusters from
other points suitably sampled in the data space. The method is tested on five
real life datasets, including micro-array gene expression data and array-CGH
data.
6.2 Introduction
Clustering is the problem of finding structure in the data by identifying groups
of objects that are more similar to each other than to objects in other groups.
The notion of similarity is domain dependent, so clustering is an ill-defined
problem for which many heuristic methods based on different approaches are
introduced (see e.g. [8] for a recent overview of clustering methods). Support
vector machine (SVM) is a powerful technique for classification and regression
[66]. In this chapter we propose a method for clustering that uses a support
vector classifier for finding support vectors which represent portions of clusters.
The method searches for support vectors close to clusters cores. Each support
vector is used to construct a (portion of a) cluster. Then an information crite-
rion is used for merging nearby (portions of) clusters.
We view clustering as a two-class classification problem, where class A con-
tains data elements while class B contains other points suitably generated.
Initially, class A consists of all the data, and class B consists of uniform points
randomly generated in the minimum hyper-rectangle containing the data. A
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soft-margin support vector classifier is trained for separating A and B, and
the non-bounded support vectors SVA of class A are considered as candidate
representatives of (portions of) clusters. Next, SVA is removed from A, B is set
to SVA, and a SVM classifier is trained to separate the resulting new classes A
and B. The idea is that at each iteration the non-bounded support vectors of
the actual class A get closer to the cores of some clusters. At each iteration the
same SVM parameters are used, with small soft-margin constant and kernel
width, resulting in few non-bounded support vectors. A heuristic criterion is
used for deciding when to stop the iterative process. The non-bounded support
vectors selected at the end of the iterative process are used for building clus-
ters by assigning each data point to the closest support vector. Finally, near
clusters are merged using a model selection criterion.
We conducted experiments on real life data sets to test the effectiveness of
this clustering method. We focused mainly on real life data sets from biological
experiments, in particular micro-array gene expression data and array-CGH
data. The results of the experiments are satisfactory and indicate that support
vector classifiers can be used in combination with a model selection criterion
for clustering.
6.3 The clustering algorithm
The clustering method employs a soft-margin SVM classifier with Gaussian
kernel
K(x, y) = e−
||x−y||2
2σ2
with width parameter σ. In the input space the points for which the SVM
decision function is equal to 1 describe boundaries enclosing the data. Support
vectors lay on or outside these boundaries, where non-bounded support vectors
1 lay on these boundaries. The SVM parameters C (see section 3.2.2) and σ
affect the form and smoothness of the boundaries. Small values of C and σ
induce smooth boundaries with few non-bounded support vectors and more
bounded ones. Non-bounded support vectors can be viewed as representatives
of portions of clusters. Clusters can be obtained by joining these portions
using a model selection criterion based on the Bayesian information criterion
(BIC) [57]. According to this criterion, the most probable model is the one
that maximizes the log-likelihood of the model given the observed data minus
a term which takes into account model dimension.
Here a model is a clustering Cl = {Cl1, . . . , Clk} of X, where X is the data
set. We use a scoring function of the form
score(Cl) = −2log-likelihood(X) + λN,
1a support vector is non-bounded if its Lagrange multiplier is smaller than C
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where N is the number of free parameters of the model and λ is a penalty
weight. (In our experiments we use λ = 5.) For the data experiments described
in Table 6.1 we formed the likelihood under the assumption that the elements
of each cluster are sampled from a spherical Gaussian distribution, with the
mean vector depending on the cluster, but the same variance for each cluster.
The smaller the score the better the model. We will compare clusterings using
score for deciding whether to join two clusters and also to choose a clustering
amongst those generated by running the clustering algorithm a number of times
with different initializations of B (see Step 1 below).
A high level description of the algorithm is given in figure 6.1, where :=
denotes variable assignment, the variables A and B denote the two classes to
be separated, R the set of support vectors selected as representatives, and Cl
the final clustering. The algorithm is called FJC (Find and Join Clusters). The
steps illustrated in figure 6.1 and 6.2 are explained below.
In Step 1, different sets B of uniform points can be generated depending
on the random seed used, which may yield different clusterings. Thus FJC is
executed a number of times and a preferred clustering is selected using score.
Two heuristic criteria are used in FJC: the way in which R is chosen in Step
2 and the strategy used for joining clusters portions in Step 4.
In Step 2 the biggest of the ClA’s generated in the iterative process is
selected as set of representatives of (portions of) clusters. This is a rather
conservative criterion based on the intuition that a higher number of non-
bounded support vectors may indicate a better separation of the classes. At
each iteration the number of elements of class A decreases, so it would seem
more intuitive to use the ratio (cardinality of ClA)/(cardinality of A). However,
experiments on artificial datasets indicate that by using this latter criterion
(representatives of) smaller clusters may be lost.
In Step 4 the algorithm tries to join portions of clusters. We use a simple
heuristic where pairs of clusters are joined if the score of the resulting clustering
decreases. Pairs of clusters are selected as follows: one cluster is chosen (in
textual order) from the actual clustering, its mean vector is computed, and
then the cluster closest to the mean vector is chosen. This heuristic has the
advantage of being fast and yielding satisfactory results.
The algorithm is implemented in Matlab and uses the Matlab implementa-
tion by Gavin C. Cawley2 of Platt SMO algorithm.
6.4 Experiments
We considered five datasets from biological experiments. The first two data
sets, available at the “University of California machine learning” (UCI ML,
[11]) repository, are often used as benchmarks for classification algorithms: the
popular Fisher iris dataset with 150 points, 4 attributes, 3 classes, 50 points
per class; the Wisconsin breast cancer wdbc with 569 points, 30 attributes,
2available at http://www.sys.uea.ac.uk/ gcc/svm/toolbox/
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FJC CLUSTERING ALGORITHM
Input. X (the dataset of size n).
Output. Cl (A clustering of X).
1. Initialization.
A := X,
B := {n randomly generated uniform points
in the hyper-rectangle containing X},
R := {},
C := C_0,
sigma := sigma_0 (in our experiments C=2, sigma=0.1).
2. Find representatives of clusters portions.
Repeat the following two steps for n_iter
(in our implementation n_iter=4).
2.a Apply SVM(C_0,sigma_0) to separate A and B,
Cl_A := {non-bounded support vectors of A},
If (Cl_A contains more elements than R)
then R := Cl_A.
2.b SV_A := {the support vectors of class A},
A := A minus SV_A,
B := SV_A,
3. Build clusters portions.
Let R = {r_1,...,r_k} (obtained from Step 2).
Cl := {Cl_1,...,Cl_k} with
Cl_i = {x in X closer to r_i than to any other r_j}.
4. Join clusters portions.
Repeat the following statement until Cl does not change.
for each Cl_i in Cl:
c_i := mean vector of Cl_i,
Find Cl_j containing a point closest to c_i,
Cl_union := (Cl-{Cl_i,Cl_j}) union {Cl_i,Cl_j},
If (score(CL_union) < score(Cl))
then Cl := Cl_union.
Figure 6.1: High level description of FJC.
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(a) Step 1. (b) Step 2a.
(c) Step 2b. (d) Step 3.
(e) Step 4. (f) Final result.
Figure 6.2: Graphical description of FJC.
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dataset data classes clusters nbsv error Jaccard robustness
cgh 55 2 4 28 1 0.95 0.69
colon 62 2 2 54 12 0.54 0.61
wdbc 569 2 7 7 22 0.35 0.74
leukemia 72 3 3 36 3 0.91 0.77
iris 150 3 3 11 11 0.78 0.75
Table 6.1: Results of FJC on five data sets.
2 classes, 357 benign and 212 malignant. The colon dataset [3] consists of
micro-array measurements of 2000 genes over 44 colon cancer and 22 non-
cancer tissues. Here we clustered tissues, so we had 62 points, and selected the
200 genes having highest variance over the tissues. The leukemia dataset [16]
consists of micro-array measurements of 12582 genes over 72 tissues of three
Leukemia types, ALL (24), MLL (20), and AML (37). We selected the 50 genes
having highest variance over the tissues. Finally the cgh data set consists of
array CGH measurements of 1354 clones of the genome over 43 stomach cancer
and 13 ovarian cancer tissues. This dataset was provided by our colleagues
at the Vrije Universiteit Medical Center of Amsterdam. We selected the 150
clones having highest variance over the tissues.
We ran FJC on each dataset 10 times and selected the best clustering
according to score. The results of the experiments are given in table 6.1,
where the columns contain: the dataset name, the number of data, the number
of classes (the “true” clusters), followed by the results of FJC, that is, the
number of clusters, the number of non-bounded support vectors, the number
of points misclassified, the Jaccard score and the robustness. The Jaccard score
is p11/(p11 + p10 + p01) where p11 is the number of pairs of points belonging to
the same cluster in both the ‘true’ and FJC clustering, p10 (respectively p01)
is the number of pairs that belong to the same cluster in the FJC (respectively
‘true’) clustering but not in the ‘true’ (respectively FJC) one.
The robustness gives an indication of FJC consistency in assigning pairs of
points to the same or different clusters over the runs. For each pair of points
xi, xj we compute the fraction fij of times they occur in the same cluster over
the 10 runs, and then aij = 1−2minimum(fij , 1−fij). For a pair of points, aij
provides a measure of the confidence of the majority vote decision of assigning
xi and xj to the same or different clusters. The confidence is 1 when xi, xj
are either always or never in the same cluster. The robustness is the average
confidence over all pairs of points.
The results indicate that FJC is a robust clustering method, capable of
identifying “true” structure in all five data sets. The misclassification errors of
FJC are comparable to those found by state-of-the-art classification methods.
In particular, on the cgh and leukemia data set FJC is able to identify the
classes almost perfectly.
In order to show the benefit of using the support vector classifier in FJC, we
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consider the algorithm obtained from FJC by removing the SVM part. This
amounts to start FJC from Step 4 with Cl consisting of one data point per
cluster. The resulting algorithm yields the following results: 3 clusters, error 4
for cgh; 2 clusters, error 15 for colon; 15 clusters, error 25 for wdbc; 2 clusters,
error 26 for leukemia; and 4 clusters, error 26 for iris.
6.5 Conclusion
This chapter showed that non-parametric clustering can be performed by using
support vector classifiers and model selection. The results indicate that FJC is
a robust clustering method, capable of identifying “true” structure in all five
data sets. In particular, on the cgh and leukemia data set FJC is able to
identify the classes almost perfectly.
6.6 Related work
The use of SVM for clustering has been proposed by Ben-Hur et al. [7]. How-
ever, they view clustering as an one-class classification problem, where the data
is distinguished from the rest of the feature space [54, 55, 63, 66] by finding a
sphere with minimal volume enclosing the data. The boundary of the sphere in
the input space forms a set of closed contours which are interpreted as cluster
boundaries, where each closed boundary forms a cluster. The authors intro-
duce a heuristic algorithm for finding these clusters, based on the observation
that two points belong to the same cluster if all the points on the line segment
connecting them lie in or on the sphere in the feature space.
A method that incorporates model selection as decision test in a clustering
algorithm has been introduced by Pelleg and Moore [43]. The authors propose
a non-parametric clustering algorithm called X-means, where a clustering is
incrementally constructed by splitting clusters and using BIC as criterion for
accepting the splittings. The algorithm is an extension of K-means with efficient
estimation of the number of clusters.
6.7 Future directions
We conclude with some issues we intend to address in future work. Alternative
ways to initialize the class B of points in Step 1 of FJC. A possibility is finding
the sphere with minimum volume in the feature space enclosing the data [63],
and consider the resulting support vectors as class B and the rest of the data
as class A. We intend to adapt the model selection criterion used for joining
clusters. We shall investigate different methods for input dimension reduction,
in order to make FJC work with high dimensional data sets.
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Chapter 7
Analyzing proteomics data
7.1 Abstract
In this chapter we analyze two proteomic pattern datasets containing measure-
ments from ovarian and prostate cancer samples. In particular, a linear and
a quadratic support vector machine (SVM) are applied to the data for distin-
guishing between cancer and benign status. On the ovarian dataset SVM gives
excellent results, while the prostate dataset seems to be a harder classification
problem for SVM. The prostate dataset is further analyzed by means of an evo-
lutionary algorithm for feature selection (EAFS) that searches for small subsets
of features in order to optimize the SVM performance. In general, the subsets
of features generated by EAFS vary over different runs and over different data
splitting in training and hold-out sets. Nevertheless, particular features occur
more frequently over all the runs. The role of these “core” features as potential
tumor biomarkers deserves further study.
7.2 Introduction
Surface-enhanced laser desorption/ionization time-of-flight mass spectronomy
(SELDI-TOFMS) is a recent laboratory technology which offers high-throughput
protein profiling. It measures the concentration of low molecular weight pep-
tides in complex mixtures, like serum (cf. e.g. [23]). Because it is relatively
inexpensive and noninvasive, it is a promising new technology for classifying
disease status. The technology is explained in more detail in section 2.4.
Given proteomic profiles for a sample of healthy and diseased individuals it
is desired to build a classifier for tumor diagnostics and to identify the protein
masses that are potentially involved in the disease. Because of the large number
of features (the m/z ratios) and the small sample size (the specimens), the
second problem is tackled using heuristic algorithms for feature selection.
In this chapter we report the analysis of two data sets obtained by applying
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SELDI-TOF MS to serum samples. The first dataset concerns measurements
from women with or without ovarian cancer, and was previously analyzed in [45,
35]. The second data set contains samples from patients with prostate cancer
and patients with benign prostate conditions, and was analyzed in [44]. Both
data sets are publicly available from the NCI/CCR and FDA/CBER Clinical
Proteomics Program Databank (http://clinicalproteomics.steem.com/).
As preliminary analysis we first investigated the extent to which single m/z
ratios can be used to discriminate the two classes of healthy and cancer state
samples. Secondly we report the error rate of support vector machine (SVM)
classifiers using the full protein profiles. It turns out that the ovarian cancer
dataset is “easy” for a linear SVM classifier, whereas the prostate cancer dataset
is “harder”.
We performed a further analysis of the prostate cancer dataset by means
of a feature selection algorithm based on EAs. We introduce an EA for fea-
ture selection, called EAFS (Evolutionary Algorithm for Feature Selection), in
order to identify small subsets of features that discriminate the healthy and
cancer groups. The results over multiple data splittings (into training, test
and validation set) and multiple EA runs show that the method is slightly
unstable. However, specific features occur most frequently in the solutions of
multiple runs. Further study is needed in order to assess the role of these “core”
features as potential tumor biomarkers.
7.3 Data analysis with all features
The “ovarian dataset” (8-7-02) consists of 253 samples, with 91 controls and
162 ovarian cancers, which include early stage cancer samples. The “prostate
dataset” contains 322 samples, with 69 cancers and 253 healthy (or benign)
samples.
We analyzed the two datasets in order to assess how difficult it is to separate
healthy and cancer groups. Figure 7.1 shows properties of the mean values of
the two classes for the ovarian dataset. Parts (a) and (b) of the figure indicate
that the healthy and cancer classes differ only in a few regions substantially in
mean. Because the variances in the two samples vary significantly with m/z
ratio, the t-test applied for each m/z ratio separately is nevertheless significant
for a much larger number of m/z ratios. In fact, as shown in part (c), there are
many p-values equal to zero all across the full range of m/z-values, and “most”
p-values are close to zero, as shown in part (d), which is a histogram with 100
bins. This seems to suggest that it is not difficult to find a good classifier for
the ovarian data set. The same information on the prostate data set is given
in Figure 7.2. We can see there are fewer features with significant difference in
mean in the prostate than in the ovarian dataset (part (d) of the figures). Thus
finding a good classifier for the prostate dataset seems to be a more difficult
task.
We classify the data using all the features and a SVM classifier. The choice
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Figure 7.1: Mean values analysis of ovarian cancer data set.
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Figure 7.2: Mean values analysis of prostate cancer data set.
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Lin., Over. Quad., Ovar. Lin. Pros. Quad. Pros.
Test Error 0.0028
(0.0061)
0.0040
(0.0065)
0.0600
(0.0201)
0.0590
(0.0246)
Sens. 0.9987
(0.0044)
0.9988
(0.0042)
0.8884
(0.0596)
0.8936
(0.0719)
Spec. 0.9947
(0.0153)
0.9912
(0.0169)
0.9539
(0.0205)
0.9552
(0.0261)
Pos. Pred.
Val.
0.9969
(0.0090)
0.9951
(0.0097)
0.8361
(0.0630)
0.8475
(0.0867)
Table 7.1: Average results over 25 runs of SVM with linear and quadratic
kernel, on ovarian and prostate data.
of SVM is motivated by its good performance also in the presence of many
features. In our experiments we use soft-margin SVM classifiers with C = 100,
and two types of kernel functions, linear and quadratic.
Table 7.1 contains the results obtained by applying an SVM classifier with
linear and quadratic kernel to the ovarian and prostate cancer data sets. Exper-
iments are conducted using the SVM software package LibSVM. We perform 25
runs, where in each run the data is randomly partitioned into training (60%)
and test (40 %) sets, a classifier is induced by the SVM learning algorithm
applied to the training set, and its classification error rate on the test set is
measured. Each entry of the table contains the average result over 25 runs
(with standard deviation written between brackets) for a specific pair of SVM
classifier and data set.
In all the runs the SVM classification error on the training set is zero.
The table contains the average test error rate, sensitivity (number of cancer
samples correctly classified divided by total number of cancer samples), speci-
ficity (number of healthy samples correctly classified divided by total number
of healthy samples), and positive predictive value (number of cancer samples
correctly classified divided by total number of samples classified as cancer).
On the ovarian dataset, the SVM classifier with linear kernel gives excellent
results, being able to output the correct diagnosis in many runs, in particular
cancer samples are almost always detected (pred. pos. val. and sensitivity are
close to 1). Thus the ovarian dataset can be considered easy for a linear SVM
classifier. Other methods applied to this dataset obtain also very good results.
In [45] a commercial package that uses a genetic algorithm (GA) based feature
selection method is applied. The GA searches in the space of all subsets of
features. It uses a fitness function that scores a feature subset according to
its ability to cluster samples in consistent groups, that is, groups containing
samples with equal class. The authors report almost perfect classification for
a specific data splitting in training and test sets. The paper does not mention
results obtained by cross-validation. A more thorough analysis of the ovarian
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data set is performed in [35], where 10-fold cross validation is applied, and dif-
ferent classification and feature selection methods are considered. Features are
first “smoothed” by means of a discretization algorithm. Perfect classification
is achieved using an SVM classifier with quadratic kernel, when all features are
used but also when a small subset of 17 features is used. This feature subset is
generated using a feature selection algorithm that iteratively constructs sets of
features using the best-first-search and a scoring criterion, for selecting a best
feature subset, which considers the correlation between pairs of features and
between feature and class.
On the prostate dataset, sensitivity and predicted positive values are lower
than specificity, possibly due to the unbalanced distribution of the two classes,
where cancer samples are about 1/3 of the healthy ones. The results indicate
that the prostate data set is somewhat harder to classify than the ovarian one,
when using SVM with a linear or quadratic kernel and all the features. In
[44] the GA-based commercial package described above is applied to this data
set. The authors identify a subset of 7 features that allow their classification
method to obtain 0.95 sensitivity, 0.78 specificity, and 0.1992 test error rate.
In summary, on the ovarian dataset a soft-margin SVM linear classifier
provides a good diagnostic tool, while for the prostate dataset the sensitivity
achieved is still too low hence does not allow a direct use of this classifier in
diagnostics. An early stage tumor diagnostic tool should have sensitivity equal
to 1 and specificity very close to 1.
7.4 An EA-based method for feature selection
In this section we describe a novel method for feature selection based on evo-
lutionary algorithms (EA). Given a dataset and a learning algorithm, the goal
of feature selection is to find a “small” subset of features that minimizes the
generalization error (that is, the classification error on new examples) of the
classifier induced by the learning algorithm when run only on the selected fea-
tures.
The data is randomly partitioned into a training, a test and a validation
sets (in the experiments these sets contain 60%, 30% and 10% of the data,
respectively). The training and test sets are used in the feature selection al-
gorithm and the validation set is used for assessing the performance of the
resulting classifier on new data. In the standard wrapper model for feature
selection, one searches for a feature subset that minimizes the test error of the
classifier trained on data restricted to that feature subset. In [40], Ng shows
that the main source of error in standard wrapper algorithms, when many irrel-
evant features are present, comes from over-fitting hold-out or cross-validation
data. He proposes an exact algorithm which is more tolerant to the presence
of many irrelevant features. The algorithm, called ordered-fs, works in two
phases. First, for each feature set size i ∈ [1,m], where m is the maximum
number of features permitted, the algorithm finds a feature set of size i that
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f unc t i on EAFS
{
generate i n i t i a l popu la t i ons
while ( te rminat ion c r i t e r i o n not s a t i s f i e d )
{
s e l e c t a populat ion
s e l e c t two parents from that populat ion
generate o f f s p r i n g using uniform c ro s s ov e r
apply mutation to o f f s p r i n g
f i nd popu la t i ons with r i gh t number o f f e a t u r e s
r ep l a c e worst i n d i v i d u a l s with o f f s p r i n g
determine f i t n e s s ( e r r o r SVM on t r a i n i n g s e t )
i f ( o f f s p r i n g has very good f i t n e s s )
apply migrat ion operator
}
}
Figure 7.3: Outline EAFS.
minimizes the classifier training error. Next, the resulting m classifiers are run
on the test set, and the one yielding minimum error is chosen.
The EA-based method we propose, called EAFS, is inspired by the ordered-
fs algorithm. The core of EAFS (illustrated in figure 7.3) consists of an EA
which evolves a number of populations, where each population consists of in-
dividuals representing feature subsets of a given size. The populations interact
by means of highly fit individuals which are used as seed for generating new
individuals of other populations. Genetic operators are used for moving in the
search space in order to minimize the SVM training error. At the end of the
evolutionary process, the best SVM classifier of each population is run on the
test set and the one yielding minimum error on this set is selected. Thus the
test set is used only to determine the optimal size of the feature set. The se-
lection of an optimal feature set of a given size is based only on the training
set.
Feature subsets are represented by bit strings of length equal to the total
number of features. A bit value equal to 1 means the corresponding feature
is considered by the learning algorithm, while a 0 means it is discarded. Indi-
viduals of each population are initialized by means of n-tournament selection
which uses a feature ranking obtained from t-tests on all single features. The
fitness of a feature subset F is equal to the training error of the SVM classifier
restricted to the features of F . Mutation removes a feature from F and adds
a new one, where both features are randomly selected. Standard GA uniform
crossover is used. While mutation does not affect the size of a feature subset,
this is not the case for crossover. Thus if the feature set size of an offspring is
different from the one of its parents, it migrates to another population. At each
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Training Test Validation
Error 0.0617 (0.0254) 0.0880 (0.0313) 0.1116 (0.0515)
Sensitivity 0.7853 (0.0926) 0.7037 (0.1193) 0.6315 (0.2069)
Specificity 0.9827 (0.0118) 0.9658 (0.0238) 0.9484 (0.0456)
Pos. Pred. Val. 0.9309 (0.0451) 0.8437 (0.0957) 0.7424 (0.2178)
Table 7.2: Results of EAFS with linear SVM
Training Test Validation
Error 0.0463 (0.0287) 0.0774 (0.0283) 0.1096 (0.0579)
Sensitivity 0.8360 (0.1096) 0.7502 (0.1249) 0.6779 (0.2177)
Specificity 0.9874 (0.0109) 0.9674 (0.0216) 0.9441 (0.0525)
Pos. Pred. Val. 0.9502 (0.0431) 0.8547 (0.0948) 0.7671 (0.1936)
Table 7.3: Results of EAFS with quadratic SVM
iteration of the EA, a population is selected and used to generate two offspring.
The EA uses tournament selection and a steady state replacement mechanism,
where offspring replace the worse individuals of the population. When the EA
terminates its execution, the best individual of each population is chosen and
the one yielding the lowest error on the test set provides the output. In the
sequel, we focus only on the application of EAFS to the prostate dataset, and
will not compare EAFS to other EA-based feature selection algorithms.
7.5 Results
We used the following experimental setup: 20 populations, each one consisting
of 10 individuals, 600 iterations, tournament selection of size 5, and crossover
and mutation rate of 0.95. These values have been chosen after a small number
of runs (using only training and test sets). We consider 24 random splitting
of the data set in training (60%), test (30%) and validation (10%) sets. For
each “split” of the data we run EAFS 25 times. This amounts to a total of
600 runs. Table 7.2 gives the results of EAFS with linear kernel. The values
are the averages over all the 600 runs. Standard deviation is reported between
brackets. Table 7.3 contains the results using a quadratic kernel. EAFS with a
quadratic kernel SVM achieves best performance, but obtains sensitivity lower
than that of SVM with all the features. However, a fair comparison is not
possible due to the different cross validation approaches used.
In order to investigate whether the data “split” influences the performance
of EAFS significantly, we perform a one-way Analysis of Variance to compare
the 24 samples of 25 validation errors resulting from the 24 “splits”. The
difference is statistically significant, with zero p-values for both the linear and
quadratic case. The “splits” explain about 24% of the variance in the validation
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Figure 7.4: Boxplot of training, test and validation errors (top to bottom),
organized by split (left) and run (right).
errors in the linear case and about 35% in the quadratic case, indicating that
76% and 65% is due to the randomness inherent in EAFS. A correction for the
effect of “split” on the error standard deviations in Tables 7.2 and 7.3 would
reduce these somewhat, but not substantially (e.g. 0.0515 becomes 0.045).
Figure 7.4 gives a visual impression of the variation due to the splitting and
EAFS. The three graphs show boxplots of the training, test and validation
errors of the 600 runs (top to bottom), organized by “split” (left) or “run”.
An important aspect of these graphs is summarized in the Figure 7.5, which
shows boxplots of the standard deviations of the 24 samples of validation errors
corresponding to the 24 “splits”. The linear SVM suffers from one extreme
split, but is otherwise more stable across relative to the splitting of the data.
We analyze now the features obtained in all the runs.
Figure 7.6 shows histograms of the final feature set sizes found over the 600
runs. The algorithm shows no preference for the largest possible feature size.
We can see that EAFS with linear SVM has a peak on feature size 5, while
EAFS with quadratic SVM prefers somewhat bigger feature sizes, with a peak
on feature size 13.
Over all the runs EAFS with linear SVM finds 3935 features, while with
quadratic SVM finds 3797 features. Figure 7.7 shows histograms of the features
occurring in the solutions found over the 600 runs. It is clear that EAFS is
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Figure 7.5: Boxplots of standard deviation within 24 runs.
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Figure 7.6: Histograms of obtained feature set sizes.
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Figure 7.7: Histograms of number of feature occurrence in final solutions.
not stable, yet the histograms indicate the presence of few frequency peaks.
By considering features occurring in these peaks, 47 features occurring in at
least 10 runs are extracted. We perform 100 runs of the linear SVM restricted
to the 47 features, with randomly chosen training and test set, and obtain
0.93 sensitivity (0.058 standard deviation) and 0.98 specificity (0.016 standard
deviation). These significantly better results may be due to the fact that the
selection of these features implicitly uses (almost) the entire dataset.
7.6 Conclusion
This chapter analyzed two proteomic pattern datasets. We applied SVM clas-
sifiers for tumor diagnostics, and used them in EAFS, an EA-based feature
selection algorithm for the identification of potential tumor markers identifi-
cation. The results do not allow us to draw strong conclusions. However, on
the ovarian data set SVM with all the features exhibits excellent performance,
while on the prostate data set it obtains relatively low sensitivity. Results of
EAFS show that its performance on the prostate data set depends on the data
splitting and EA run. Moreover, feature subsets generated by EAFS vary per
run, with a small core of features occurring more often. This latter phenomenon
was observed to happen also in the other methods discussed in this chapter.
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7.7 Future work
Future work includes the incorporation of a pre-processing phase into EAFS;
the investigation of other types of classifiers; the use of knowledge-based muta-
tion operators; and the use of multiple EAFS’s runs with different splitting of
training and test sets for extracting a “core” set of features from the resulting
EAFS’s solutions.
Chapter 8
Conclusions
Although the individual chapters have their specific results and conclusions, a
higher level conclusion from this thesis is presented here.
The recent technological developments enable biologists to perform large
scale measurements at various “information levels” in the human cell. Although
these technologies provide interesting new opportunities, there are problems to
deal with, such as experimental noise and incomparable experiments due to
differences in the technique used at different institutes. In chapter 4 multiple
algorithms are compared to optimize a likelihood criterion to reduce the noise
in array CGH experiments. The finally chosen algorithm obtains results similar
to expert opinion. A user-friendly software tool was developed to make this
algorithm available to the array CGH community. Chapter 5 deals with the
incomparability of the different dual channel array CGH platforms. Next to
developing a preprocessing procedure to make the experiments comparable,
this chapter makes preliminary investigations to identify relevant chromosomal
areas to distinguish different tumor types. Much new information may be
gained using meta-analysis, whenever a new series of experiments are performed
on whichever array CGH platform.
On the RNA level we showed that non-parametric clustering can be per-
formed by using support vector classifiers and model selection. The results
indicate that our method is a robust clustering method, capable of identifying
“true” structure in all used data sets. The misclassification errors are compara-
ble to those found by state-of-the-art classification methods. This is explained
in chapter 6.
Chapter 7 deals with data on the protein level. We applied SVM classifiers
for tumor diagnostics, and used them in an EA-based feature selection algo-
rithm for the identification of potential tumor markers identification. A series
of experiments indicates that a relatively small part of the SELDI-TOF spec-
trum emerges as important to distinguish healthy persons from those diagnosed
to have cancer.
Reproducibility and reliability of results are two issues in the analysis of
93
94 CHAPTER 8. CONCLUSIONS
gene expression and pattern proteomic data [36, 22]. For instance, overopti-
mistic prognostic results are sometimes published [37]. Modern techniques for
proteomics, such as SELDI-TOF, have not yet fully matured and sometimes
cause a controversy [5, 34]. However, this issue is less problematic for array
CGH, since a common reference (normal human cells) is used, which makes the
data much easier to interpret.
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Samenvatting
Het onderwerp van dit proefschrift is “Machinaal leren voor menselijk kanker
onderzoek”. Algoritmes die onder machinaal leren vallen, kunnen op veel ge-
bieden van kanker onderzoek worden toegepast. Dit proefschift is ingedeeld
naar de centrale informatiestroom die in een menselijke cel plaatsvindt. Deze
houdt in dat DNA resulteert in RNA dat op zijn beurt in eiwitten resulteert.
Hoofdstuk 1 is de introductie, hoofdstuk 2 geeft een beknopte introductie
in moleculaire biologie en hoofdstuk 3 geeft een korte introductie in de compu-
tationele methoden die gebruikt zijn.
Hoofdstuk 4 presenteert een algoritme om ruis te verminderen in de data
gegenereerd door de array CGH techniek. Met behulp van array CGH experi-
menten kunnen chromosomale afwijkingen in cellen van tumor weefsel worden
vastgesteld. Chromosomale afwijkingen op specifieke locaties op het genoom
kunnen een aanwijzing zijn voor de aanwezigheid van genen die kankervorming
onderdrukken of juist versterken. Er zijn echter veel potentie¨le bronnen van ruis
in de experimenten. Om dit probleem aan te pakken hebben wij een “Smooth-
ing” (glad maken) procedure en daarop gebaseerd programma ontwikkeld. De
chromosomale afwijkingen die wij hiermee hebben gevonden, zijn vergelijkbaar
met die van een expert die de onbewerkte data beoordeelt.
Hoofdstuk 5 beschrijft een methode om array CGH experimenten van ver-
schillende platformen met elkaar te kunnen vergelijken, met een toepassing op
een grote data set. Array CGH platformen kunnen verschillen in een aantal
opzichten, zoals het aantal lokaties op het genoom dat gemeten wordt en welke
lokaties er gemeten worden, maar ook in de ruisverdeling. Het kunnen vergeli-
jken van verschillende platformen stelt ons in staat op eenvoudige wijze veel
experimenten uit verschillende studies te kunnen vergelijken. De methode die
wij hebben ontwikkeld maakt onder andere gebruik van ons “Smoothing” algo-
ritme. De resultaten suggereren dat onze methode een succesvolle vergelijking
van verschillende platformen mogelijk maakt.
Hoofdstuk 6 verschuift de aandacht van het DNA-niveau naar het RNA-
niveau. Het hoofdstuk beschrijft een nieuwe clusteringmethode die gebruik
maakt van de SVM classificatiemethode. De expressieniveaus van de genen in
een cel bepalen hoe een cel zich gedraagt en kunnen dus interessante informatie
geven over de tumorcellen. Vanuit een informatica perspectief is het interessant
te proberen ideee¨n uit een succesvolle classificatiemethode toe te passen in
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een clusteringalgoritme. Hierbij hebben wij het clusteringprobleem vertaald
naar een classificatie probleem met 2 klassen. De resultaten geven aan dat de
clustering redelijk robuust is en zich kan meten met een aantal gangbare en
goede clusteringalgoritmen.
Hoofdstuk 7 verschuift de aandacht van het RNA-niveau naar het eiwit-
niveau. Een methode gebaseerd op Support Vector Machines en evolution-
aire algoritmen wordt beschreven. Er wordt gebruik gemaakt van data van
2 soorten kanker en van data van gezonde personen. Hiermee worden delen
van het SELDI-TOF spectrum achterhaald, die belangrijk zijn om onderscheid
te kunnen maken tussen de zieke en gezonde personen. Een serie van experi-
menten geeft aan dat een relatief kleine verzameling punten uit het SELDI-TOF
spectrum veelvuldig terugkeert.
Tenslotte geeft hoofdstuk 8 een beknopte conclusie van dit werk.
